FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Luc Harousseau

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Heinz Ludwig; Tamas Masszi; Bruno Paiva; Deborah Ricci; Don Robinson; Ofer Shpilberg; Ivan Spicka; Anne Marie Stoppa; Helgi van de Velde; María-Belén Vidriales; Luisa Viterbo; Andrew Cakana; Anna Dmoszynska; Christopher Enny; Graca Esteves; Huaibao Feng; Richard Greil; Roman Hajek; Jean-Luc Harousseau
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.
Romain Guièze; Jean-Luc Harousseau; Chantal Himberlin; Norbert Ifrah; Bruno Lioure; Arnaud Pigneux; Christian Recher; Pascal Turlure; Norbert Vey; Marie C Béné; Odile Blanchet; Caroline Bonmati; Didier Bouscary; Claude-Eric Bulabois; Patrice Chevallier; Pascale Cornillet-Lefebvre; Martine Delain; Francois Dreyfus; Nathalie Fegueux
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
Steven Le Gouill; C Leux; Noël Milpied; U Bacher; K Bouabdallah; Claude-Eric Bulabois; Agnès Buzyn; Nathalie Dhedin; Jean-Luc Harousseau; T Kanouni; N Kröger; M P Moles; Philippe Moreau; Arnon Nagler; S Ocheni; Bernard Rio; A Shimoni; Olivier Tournilhac; Ibrahim Yakoub-Agha; Mohamad Mohty
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Luc Harousseau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Heinz Ludwig; Tamas Masszi; Bruno Paiva; Deborah Ricci; Don Robinson; Ofer Shpilberg; Ivan Spicka; Anne Marie Stoppa; Helgi van de Velde; María-Belén Vidriales; Luisa Viterbo; Andrew Cakana; Anna Dmoszynska; Christopher Enny; Graca Esteves; Huaibao Feng; Richard Greil; Roman Hajek; Jean-Luc Harousseau
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):247-55.
2012: Romain Guièze; Jean-Luc Harousseau; Chantal Himberlin; Norbert Ifrah; Bruno Lioure; Arnaud Pigneux; Christian Recher; Pascal Turlure; Norbert Vey; Marie C Béné; Odile Blanchet; Caroline Bonmati; Didier Bouscary; Claude-Eric Bulabois; Patrice Chevallier; Pascale Cornillet-Lefebvre; Martine Delain; Francois Dreyfus; Nathalie Fegueux
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
American journal of hematology 2012;87(12):1052-6.
2012: Steven Le Gouill; C Leux; Noël Milpied; U Bacher; K Bouabdallah; Claude-Eric Bulabois; Agnès Buzyn; Nathalie Dhedin; Jean-Luc Harousseau; T Kanouni; N Kröger; M P Moles; Philippe Moreau; Arnon Nagler; S Ocheni; Bernard Rio; A Shimoni; Olivier Tournilhac; Ibrahim Yakoub-Agha; Mohamad Mohty
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2695-703.
2012: Pierre Peterlin; Virginie Roland; Soraya Wuilleme; Christophe Leux; Béatrice Mahé; Noel Milpied; Mohamad Mohty; Anne Moreau; Philippe Moreau; Sameh Ayari; Nicolas Blin; Patrice Chevallier; Aline Clavert; Jacques Delaunay; Christelle Dousset; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Jean-Luc Harousseau; Steven Le Gouill
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?
Transplantation 2012;94(3):295-301.
2012: Philippe Moreau; Robert Z Orlowski; Antonio Palumbo; Paul G Richardson; Jesús F San Miguel; Michele Cavo; Jean-Luc Harousseau
Proteasome inhibitors in multiple myeloma: 10 years later.
Blood 2012;120(5):947-59.
2012: Mauricette Michallet; Noel Milpied; Mohamad Mohty; Stéphane Morisset; Franck E Nicolini; Mohamad Sobh; Reza Tabrizi; Nathalie Tedone; Stéphane Vigouroux; Joachim Baumgart; Jacques-Olivier Bay; Sabine Fürst; Jean-Luc Harousseau; Hélène Labussière; Didier Blaise
Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.
Annals of hematology 2012;91(8):1289-97.
2012: Laurent Garderet; Norbert-Claude Gorin; Alois Gratwohl; Roman Hajek; Jean-Luc Harousseau; Bernd Hertenstein; Simona Iacobelli; Nicolas Ketterer; Christian Koenecke; Brigitte Kolb; Ingrid Lafon; Heinz Ludwig; Tamas Masszi; Mauricette Michallet; Giuseppe Milone; Mohamad Mohty; Philippe Moreau; Curly Morris; Dietger Niederwieser; Francesco Onida; Brigitte Pegourie; Marleen van Os; Andrew Cakana; Philippe Casassus; Carine Chaleteix; Theo de Witte; Michel DIB; Chantal Doyen; Jean Fontan; Gösta Gahrton
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(20):2475-82.
2012: Sagar Lonial; Amitabha Mazumder; Philippe Moreau; Anil K Singhal; L Claire Tsao; Ravi Vij; Christopher Westland; Thierry Facon; Jean-Luc Harousseau; Jonathan L Kaufman; Xavier Leleu; Sundar Jagannath
Elotuzumab in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(16):1953-9.
2012: Caroline Rousseau; Stéphane Supiot; John Wijdenes; Jacques Barbet; Manuel Bardiès; Pierre Baumgartner; François Davodeau; Alain Faivre-Chauvet; Ludovic Ferrer; Thierry Guillaume; Jean-Luc Harousseau; Françoise Kraeber-Bodéré; Marie Lacombe; Philippe Moreau; Michel Cherel
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(3):679-88.
2012: R Houot; Steven Le Gouill; H Maisonneuve; M P Moles; C Mounier; M Ojeda Uribe; P Rodon; L Sutton; Olivier Tournilhac; M Alexis Vigier; N Arakelyan; D Assouline; K Bouabdallah; Sylvie Caulet-Maugendre; S Courby; C Dartigeas; A El Yamani; L Fornecker; Rémy Gressin; Jean-Luc Harousseau
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(6):1555-61.
2012: Michel Attal; Hervé Avet-Loiseau; Lotfi Benboubker; Denis Caillot; Olivier Decaux; Charles Dumontet; Thierry Facon; Laurent Garderet; Jean-Luc Harousseau; Cyrille Hulin; Valerie Lauwers-Cances; Xavier Leleu; Serge Leyvraz; Gerald Marit; Claire Mathiot; Mauricette Michallet; Philippe Moreau; Catherine Payen; Brigitte Pegourie; Murielle Roussel; Anne Marie Stoppa; Marie-Christiane Vekemans; Laurent Voillat
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
The New England journal of medicine 2012;366(19):1782-91.
2012: Paul G Richardson; O Sezer; D Siegel; E Terpos; S Usmani; D Vesole; P Voorhees; P Wen; Kenneth C Anderson; H Avet-Loiseau; M Beksac; J Bladé; M Cavo; W J Chng; R Comenzo; M Delforge; M Dimopoulos; B G M Durie; H Einsele; Jean-Luc Harousseau; Sundar Jagannath; J L Jongen; J J Lahuerta; J H Lee; Sagar Lonial; M-V Mateos; A Mazumder; G Merlini; J San Miguel; P Moreau; G Morgan; N Munshi; R Niesvizky; Robert Z Orlowski; Antonio Palumbo; S V Rajkumar; Pieter Sonneveld
Management of treatment-emergent peripheral neuropathy in multiple myeloma.
Leukemia 2012;26(4):595-608.
2012: Bruno Lioure; Isabelle Luquet; Mario Ojeda-Uribe; Arnaud Pigneux; Edouard Randriamalala; Brigitte Witz; Marie C Béné; Christian Berthou; Didier Blaise; Odile Blanchet; Didier Bouscary; Jean-Yves Cahn; Martin Carré; Patrice Chevallier; Pascale Cornillet-Lefebvre; Jérôme Cornillon; Martine Delain; Nathalie Fegueux; Luc Fornecker; Jean-Luc Harousseau; Mathilde Hunault; A Huynh; Norbert Ifrah; Thierry Lamy; Fabrice Larosa
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.
Blood 2012;119(12):2943-8.
2012: Ibrahim Yakoub-Agha; Robert Zerbib; Lotfi Benboubker; Christian Berthou; Philippe Casassus; Ghandi Damaj; Mamoun Dib; Chantal Doyen; Thierry Facon; Jean-Luc Harousseau; Cyrille Hulin; Frédéric Maloisel; Gérald Marit; Jean-Yves Mary; Mohamad Mohty; Philippe Moreau; Brigitte Pegourie; Philippe Rodon; Borhane Slama; Anne-Marie Stoppa; Laurent Voillat
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
European journal of haematology 2012;88(3):249-59.
2012: Z Peric; B Saulquin; Philippe Moreau; S Ayari; N Blin; E Brissot; X Cahu; Patrice Chevallier; Marianne Coste-Burel; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Jean-Luc Harousseau; Berthe-Marie Imbert-Marcille; Steven Le Gouill; Béatrice Mahé; F Malard; Mohamad Mohty
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation.
Bone marrow transplantation 2012;47(2):251-7.
2011: Philippe Moreau; Brigitte Pégourié; Edouard Randriamalala; Catherine Sebban; Anne Marie Stoppa; Mourad Tiab; Catherine Traullé; Marc Wetterwald; Cyrille Hulin; Brigitte Kolb; Pascal Lenain; Gérard Lepeu; Bruno Lioure; Gerald Marit; Claire Mathiot; Carla Araujo; Michel Attal; Herve Avet-Loiseau; Lotfi Benboubker; Christian Berthou; Denis Caillot; Carine Chaleteix; Olivier Decaux; Mamoun Dib; Chantal Doyen; Martine Escoffre; Thierry Facon; Jean Fontan; Jean-Gabriel Fuzibet; Laurent Garderet; Jean-Luc Harousseau
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.
Blood 2011;118(22):5752-8; quiz 5982.
2011: Florent Malard; Noel Miplied; Philippe Moreau; Sameh Ayari; Nicolas Blin; Eolia Brissot; Xavier Cahu; Patrice Chevallier; Aline Clavert; Jacques Delaunay; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Jean-Luc Harousseau; Steven Le Gouill; Béatrice Mahe; Mohamad Mohty
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1698-703.
2011: Jatin Shah; Pieter Sonneveld; Joan Bladé; Jean-Luc Harousseau; Keith Lantz; Anil Londhe; Colin Lowery; Robert Z Orlowski
Rapid early monoclonal protein reduction after therapy with bortezomib or bortezomib and pegylated liposomal doxorubicin in relapsed/refractory myeloma is associated with a longer time to progression.
Cancer 2011;117(16):3758-62.
2011: Aurore Perrot; Arnaud Pigneux; Edouard Randriamalala; Christian Recher; Norbert Vey; Francis Witz; Carole Barin; Marie C Béné; Christian Berthou; Jean-Yves Cahn; Jacques Delaunay; Nathalie Fegueux; Philippe Guardiola; Jean-Luc Harousseau; Chantal Himberlin; Norbert Ifrah; Bruno Lioure; Isabelle Luquet; Francine Mugneret; Mario Ojeda-Uribe
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities.
Blood 2011;118(3):679-85.
2011: Philippe Moreau; M Attal; Jean-Luc Harousseau
New developments in conditioning regimens before auto-SCT in multiple myeloma.
Bone marrow transplantation 2011;46(7):911-5.
2011: Z Peric; B Saulquin; Philippe Moreau; S Ayari; N Blin; E Brissot; X Cahu; Patrice Chevallier; Marianne Coste-Burel; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Jean-Luc Harousseau; Berthe-Marie Imbert-Marcille; Steven Le Gouill; Béatrice Mahe; F Malard; Noël Milpied; Mohamad Mohty
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.
Leukemia 2011;25(6):932-8.
2011: Patrice Chevallier; P Cornillet-Lefebvre; M-C Bene; O Blanchet; K Filanovsky; N Gachard; Jean-Luc Harousseau; M Hunault; N Ifrah; Myriam Labopin; L Lode; I Luquet; Noël Milpied; Mohamad Mohty; A Pigneux; T Prebet; S Richebourg; P Turlure; N Vey; J Delaunay
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study.
Leukemia 2011;25(6):939-44.
2011: Philippe Moreau; Hervé Avet-Loiseau; Jean-Luc Harousseau; Michel Attal
Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(14):1898-906.
2011: Nikhil C Munshi; Antonio Palumbo; S Vincent Rajkumar; Jesus San Miguel; Orhan Sezer; John Shaughnessy; Pieter Sonneveld; A Keith Stewart; Kenneth C Anderson; Hervé Avet-Loiseau; P Leif Bergsagel; Michele Cavo; John Crowley; Meletios Dimopoulos; Brian Durie; Rafael Fonseca; Roman Hajek; Jean-Luc Harousseau; Sundar Jagannath; Robert Kyle
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.
Blood 2011;117(18):4696-700.
2011: S Vincent Rajkumar; Paul Richardson; Jesús San Miguel; Orhan Sezer; David Siegel; David H Vesole; Jeffrey A Zonder; Kenneth C Anderson; Hervé Avet-Loiseau; Joan Blade; Meletios Dimopoulos; Brian G M Durie; Thierry Facon; Jean-Luc Harousseau; Sundar Jagannath; Robert Kyle; Sagar Lonial; Heinz Ludwig; Nikhil C Munshi; Robert Z Orlowski; Antonio Palumbo
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Blood 2011;117(18):4691-5.
2011: Philippe Moreau; Halyna Pylypenko; Sebastian Grosicki; Ievgenii Karamanesht; Xavier Leleu; Maria Grishunina; Grigoriy Rekhtman; Zvenyslava Masliak; Tadeusz Robak; Anna Shubina; Bertrand Arnulf; Martin Kropff; James Cavet; Dixie Esseltine; Huaibao Feng; Suzette Girgis; Helgi van de Velde; William Deraedt; Jean-Luc Harousseau
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.
The lancet oncology 2011;12(5):431-40.
2011: Philippe Moreau; F Cavallo; Xavier Leleu; Cyrille Hulin; Martine Amiot; G Descamps; Thierry Facon; Mario Boccadoro; D Mignard; Jean-Luc Harousseau
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma.
Leukemia 2011;25(5):872-4.
2011: Meletios A Dimopoulos; Antonio Palumbo; M Attal; M Beksaç; F E Davies; M Delforge; H Einsele; R Hajek; Jean-Luc Harousseau; F Leal da Costa; Heinz Ludwig; U-H Mellqvist; G J Morgan; J F San-Miguel; S Zweegman; Pieter Sonneveld
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement.
Leukemia 2011;25(5):749-60.
2011: Philippe Moreau; Michel Attal; Brigitte Pégourié; Lucie Planche; Cyrille Hulin; Thierry Facon; Anne-Marie Stoppa; Jean-Gabriel Fuzibet; Bernard Grosbois; Chantal Doyen; Nicolas Ketterer; Catherine Sebban; Brigitte Kolb; Carine Chaleteix; Mamoun Dib; Laurent Voillat; Jean Fontan; Laurent Garderet; Jérôme Jaubert; Claire Mathiot; Dixie Esseltine; Hervé Avet-Loiseau; Jean-Luc Harousseau
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.
Blood 2011;117(11):3041-4.
2011: Reyna Favis; Yu Sun; Helgi van de Velde; Erin Broderick; Laura Levey; Michael Meyers; George Mulligan; Jean-Luc Harousseau; Paul G Richardson; Deborah S Ricci
Genetic variation associated with bortezomib-induced peripheral neuropathy.
Pharmacogenetics and genomics 2011;21(3):121-9.
2011: V Roland; Caroline Bodet-Milin; Anne Moreau; Thomas Gastinne; Béatrice Mahé; V Dubruille; Hervé Maisonneuve; Nadine Juge-Morineau; Philippe Moreau; Henri Jardel; L Planche; Mohamad Mohty; P Moreau; Jean-Luc Harousseau; Françoise Kraeber-Bodéré; Steven Le Gouill
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.
Bone marrow transplantation 2011;46(3):393-9.
2011: Hervé Avet-Loiseau; Florent Malard; Loic Campion; Florence Magrangeas; Catherine Sebban; Bruno Lioure; Olivier Decaux; Thierry Lamy; Laurence Legros; Jean-Gabriel Fuzibet; Mauricette Michallet; Bernadette Corront; Pascal Lenain; Cyrille Hulin; Claire Mathiot; Michel Attal; Thierry Facon; Jean-Luc Harousseau; Stephane Minvielle; Philippe Moreau
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Blood 2011;117(6):2009-11.
2011: Joan Bladé; Pieter Sonneveld; Jesús F San Miguel; Heather J Sutherland; Roman Hajek; Arnon Nagler; Andrew Spencer; Tadeusz Robak; Keith C Lantz; Sen H Zhuang; Jean-Luc Harousseau; Robert Z Orlowski
Efficacy and safety of pegylated liposomal Doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome.
Clinical lymphoma, myeloma & leukemia 2011;11(1):44-9.
2011: Jesús F San Miguel; Meletios A Dimopoulos; Edward A Stadtmauer; S Vincent Rajkumar; David Siegel; Marie-Laure Bravo; Marta Olesnyckyj; Robert D Knight; Jerome B Zeldis; Jean-Luc Harousseau; Donna M Weber
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
Clinical lymphoma, myeloma & leukemia 2011;11(1):38-43.
2011: Murielle Roussel; Thierry Facon; Philippe Moreau; Jean-Luc Harousseau; Michel Attal
Firstline treatment and maintenance in newly diagnosed multiple myeloma patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2011;183():189-206.
2011: Heinz Ludwig; Meral Beksac; Joan Bladé; Jamie Cavenagh; Michele Cavo; Michel Delforge; Meletios Dimopoulos; Johannes Drach; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Jean-Luc Harousseau; Urs Hess; Martin Kropff; Fernando Leal da Costa; Vernon Louw; Hila Magen-Nativ; Larisa Mendeleeva; Hareth Nahi; Torben Plesner; Jesús San-Miguel; Pieter Sonneveld; Miklos Udvardy; Pia Sondergeld; Antonio Palumbo
Multiple myeloma treatment strategies with novel agents in 2011: a European perspective.
The oncologist 2011;16(4):388-403.
2010: Philippe Moreau; Arnaud Jaccard; Lotfi Benboubker; Bruno Royer; Xavier Leleu; Franck Bridoux; Gilles Salles; Veronique Leblond; Murielle Roussel; May Alakl; Olivier Hermine; Lucie Planche; Jean-Luc Harousseau; Jean-Paul Fermand
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study.
Blood 2010;116(23):4777-82.
2010: Jean-Luc Harousseau
Ten years of improvement in the management of multiple myeloma: 2000-2010.
Clinical lymphoma, myeloma & leukemia 2010;10(6):424-42.
2010: Curly Morris; Mary Drake; Jane Apperley; Simona Iacobelli; Anja van Biezen; Bo Bjorkstrand; Hartmut Goldschmidt; Jean-Luc Harousseau; Gareth Morgan; Theo de Witte; Dietger Niederwieser; Gosta Gahrton
Efficacy and outcome of autologous transplantation in rare myelomas.
Haematologica 2010;95(12):2126-33.
2010: Meletios A Dimopoulos; Evangelos Terpos; Asher Chanan-Khan; Nelson Leung; Heinz Ludwig; Sundar Jagannath; Ruben Niesvizky; Sergio Giralt; Jean-Paul Fermand; Joan Bladé; Raymond L Comenzo; Orhan Sezer; Antonio Palumbo; Jean-Luc Harousseau; Paul G Richardson; Bart Barlogie; Kenneth C Anderson; Pieter Sonneveld; Patrizia Tosi; Michele Cavo; S Vincent Rajkumar; Brian G M Durie; Jésus San Miguel
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4976-84.
2010: Charalampia Kyriakou; Carmen Canals; Jan J Cornelissen; Gerard Socié; Roel Willemze; Norbert Ifrah; Hildegard T Greinix; Didier Blaise; Eric Deconinck; Augustin Ferrant; Anton Schattenberg; Jean-Luc Harousseau; Anna Sureda; Norbert Schmitz
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4926-34.
2010: Jean-Luc Harousseau; Antonio Palumbo; Paul G Richardson; Rudolf Schlag; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Alain Kentos; Michele Cavo; Anatoly Golenkov; Mieczyslaw Komarnicki; Maria-Victoria Mateos; Dixie Esseltine; Andrew Cakana; Kevin Liu; William Deraedt; Helgi van de Velde; Jesús F San Miguel
Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone.
Blood 2010;116(19):3743-50.
2010: Laurence Lodé; Marion Eveillard; Valérie Trichet; Thierry Soussi; Soraya Wuillème; Steven Richebourg; Florence Magrangeas; Norbert Ifrah; Loïc Campion; Catherine Traullé; François Guilhot; Denis Caillot; Gérald Marit; Claire Mathiot; Thierry Facon; Michel Attal; Jean-Luc Harousseau; Philippe Moreau; Stéphane Minvielle; Hervé Avet-Loiseau
Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma.
Haematologica 2010;95(11):1973-6.
2010: Gabriele Buda; Deborah Ricci; C Chris Huang; Reyna Favis; Nadine Cohen; Sen H Zhuang; Jean-Luc Harousseau; Pieter Sonneveld; Joan Bladé; Robert Z Orlowski
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin.
Annals of hematology 2010;89(11):1133-40.
2010: Jean-Luc Harousseau; Michel Attal; Hervé Avet-Loiseau; Gerald Marit; Denis Caillot; Mohamad Mohty; Pascal Lenain; Cyrille Hulin; Thierry Facon; Philippe Casassus; Mauricette Michallet; Hervé Maisonneuve; Lotfi Benboubker; Frédéric Maloisel; Marie-Odile Petillon; Iain Webb; Claire Mathiot; Philippe Moreau
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(30):4621-9.
2010: Hervé Avet-Loiseau; Xavier Leleu; Murielle Roussel; Philippe Moreau; Catherine Guerin-Charbonnel; Denis Caillot; Gérald Marit; Lotfi Benboubker; Laurent Voillat; Claire Mathiot; Brigitte Kolb; Margaret Macro; Loïc Campion; Marc Wetterwald; Anne-Marie Stoppa; Cyrille Hulin; Thierry Facon; Michel Attal; Stéphane Minvielle; Jean-Luc Harousseau
Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(30):4630-4.
2010: Jean-Luc Harousseau
Multiple myeloma in the elderly: when to treat, when to go to transplant.
Oncology (Williston Park, N.Y.) 2010;24(11):992-8.
2010: Evangelos Terpos; Meletios A Dimopoulos; O Sezer; D Roodman; N Abildgaard; R Vescio; P Tosi; R Garcia-Sanz; F Davies; A Chanan-Khan; Antonio Palumbo; Pieter Sonneveld; M T Drake; Jean-Luc Harousseau; Kenneth C Anderson; B G M Durie
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Leukemia 2010;24(10):1700-12.
2010: Jean-Luc Harousseau; Meletios A Dimopoulos; Michael Wang; Alessandro Corso; Christine Chen; Michel Attal; Andrew Spencer; Zhinuan Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight; Donna M Weber
Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma.
Haematologica 2010;95(10):1738-44.
2010: Franck Morschhauser; Françoise Kraeber-Bodéré; William A Wegener; Jean-Luc Harousseau; Marie-Odile Petillon; Damien Huglo; Lorenz H Trümper; Johannes Meller; Michael Pfreundschuh; Carl-Martin Kirsch; Ralph Naumann; Joachim Kropp; Heather Horne; Nick Teoh; Steven Le Gouill; Caroline Bodet-Milin; Jean-François Chatal; David M Goldenberg
High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3709-16.
2010: Aline Clavert; Steven Le Gouill; Eolia Brissot; Viviane Dubruille; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Beatrice Saulquin; Anne Moreau; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied; Mohamad Mohty
Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma.
Leukemia & lymphoma 2010;51(8):1502-8.
2010: Caroline Bodet-Milin; Cyrille Touzeau; Christophe Leux; Mehmet Sahin; Anne Moreau; Hervé Maisonneuve; Nadine Morineau; Henri Jardel; Philippe Moreau; Céline Gallazini-Crépin; Pascal Gries; Rémy Gressin; Jean-Luc Harousseau; Mohamad Mohty; Philippe Moreau; Françoise Kraeber-Bodere; Steven Le Gouill
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
European journal of nuclear medicine and molecular imaging 2010;37(9):1633-42.
2010: P Chevallier; L Fornecker; Bruno Lioure; M C Béné; A Pigneux; C Recher; Brigitte Witz; N Fegueux; Claude-Eric Bulabois; S Daliphard; D Bouscary; Norbert Vey; Martine Delain; Jacques-Olivier Bay; P Turlure; Marc Bernard; C Himberlin; I Luquet; Norbert Ifrah; Jean-Luc Harousseau
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
Leukemia 2010;24(7):1380-5.
2010: James R Berenson; Kenneth C Anderson; Robert A Audell; Ralph V Boccia; Morton Coleman; Meletios A Dimopoulos; Matthew T Drake; Rafael Fonseca; Jean-Luc Harousseau; Douglas Joshua; Sagar Lonial; Ruben Niesvizky; Antonio Palumbo; G David Roodman; Jesus F San-Miguel; Seema Singhal; Donna M Weber; Maurizio Zangari; Eric Wirtschafter; Ori Yellin; Robert A Kyle
Monoclonal gammopathy of undetermined significance: a consensus statement.
British journal of haematology 2010;150(1):28-38.
2010: Arnaud Pigneux; Jean-Luc Harousseau; Francis Witz; Mathieu Sauvezie; Marie-Christine Bene; Isabelle Luquet; Mathilde Hunault-Berger; Christian Recher; Bruno Lioure; Chantal Himberlin; Martine Escoffre-Barbe; Christian Berthou; Severine Lissandre; Nathalie Fegueux; Jean-Yves Cahn; Eric Jourdan; François Dreyfus; Josy Reiffers; Noël Milpied; Norbert Ifrah
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(18):3028-34.
2010: Philippe Moreau; Cyrille Hulin; Gérald Marit; Denis Caillot; Thierry Facon; P Lenain; Christian Berthou; B Pégourié; Anne-Marie Stoppa; Philippe Casassus; Mauricette Michallet; Lotfi Benboubker; H Maisonneuve; Chantal Doyen; S Leyvraz; Claire Mathiot; Hervé Avet-Loiseau; Michel Attal; Jean-Luc Harousseau
Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial.
Leukemia 2010;24(6):1233-5.
2010: Jean-Luc Harousseau; M Dreyling
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v155-7.
2010: Jean-Luc Harousseau
Optimising patient outcomes in myeloma.
Cancer treatment reviews 2010;36 Suppl 2():S33-5.
2010: Jean-Luc Harousseau
Clinical management of myeloma--state of the art.
Cancer treatment reviews 2010;36 Suppl 2():S1-2.
2010: C Cleyrat; J Jelinek; F Girodon; M Boissinot; T Ponge; Jean-Luc Harousseau; Jean-Pierre J Issa; Sylvie Hermouet
JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5.
Leukemia 2010;24(5):1069-73.
2010: E Brissot; Patrice Chevallier; T Guillaume; J Delaunay; S Ayari; V Dubruille; Steven Le Gouill; B Mahe; Thomas Gastinne; N Blin; B Saulquin; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.
Bone marrow transplantation 2010;45(4):786-8.
2010: Heinz Ludwig; Vanessa Bolejack; John Crowley; Joan Bladé; Jesus San Miguel; Robert A Kyle; S Vincent Rajkumar; Kazuyuki Shimizu; Ingemar Turesson; Jan Westin; Pieter Sonneveld; Michele Cavo; Mario Boccadoro; Antonio Palumbo; Patrizia Tosi; Jean-Luc Harousseau; Michel Attal; Bart Barlogie; A Keith Stewart; Brian G M Durie
Survival and years of life lost in different age cohorts of patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1599-605.
2010: Bart Barlogie; Michel Attal; John Crowley; Frits van Rhee; Jackie Szymonifka; Philippe Moreau; Brian G M Durie; Jean-Luc Harousseau
Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(7):1209-14.
2010: Bilal Mohty; Jean El-Cheikh; Ibrahim Yakoub-Agha; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.
Haematologica 2010;95(2):311-9.
2010: P Chevallier; T Prebet; A Pigneux; M Hunault; J Delaunay; F Perry; L Lode; S Richebourg; O Blanchet; N Vey; N Ifrah; N Milpied; D Blaise; Jean-Luc Harousseau; M Mohty
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.
Leukemia 2010;24(2):467-9.
2010: Murielle Roussel; Philippe Moreau; A Huynh; Jean-Yves Mary; Clotaire Danho; Denis Caillot; Cyrille Hulin; Christophe Fruchart; Gérald Marit; Brigitte Pégourié; Pascal Lenain; Carla Araujo; Brigitte Kolb; Edouard Randriamalala; Bruno Royer; Anne-Marie Stoppa; Mamoun Dib; Véronique Dorvaux; Laurent Garderet; Claire Mathiot; Hervé Avet-Loiseau; Jean-Luc Harousseau; Michel Attal
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).
Blood 2010;115(1):32-7.
2010: Heinz Ludwig; Meral Beksac; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Michele Cavo; Meletios Dimopoulos; Johannes Drach; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Jean-Luc Harousseau; Urs Hess; Nicolas Ketterer; Martin Kropff; Larisa Mendeleeva; Gareth Morgan; Antonio Palumbo; Torben Plesner; Jesús San Miguel; Ofer Shpilberg; Pia Sondergeld; Pieter Sonneveld; Sonja Zweegman
Current multiple myeloma treatment strategies with novel agents: a European perspective.
The oncologist 2010;15(1):6-25.
2010: Florent Malard; Richard M Szydlo; Eolia Brissot; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Viviane Dubruille; Steven Le Gouill; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Beatrice Saulquin; Jean-Luc Harousseau; Philippe Moreau; Mohamad Mohty
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):28-34.
2010: Patrice Chevallier; T Prebet; P Turlure; Mathilde Hunault; Stéphane Vigouroux; Jean-Luc Harousseau; Didier Blaise; Norbert Ifrah; Noël Milpied; Mohamad Mohty
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2010;45(1):165-70.
2009: Xavier Cahu; Fanny Rialland; Cyrille Touzeau; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Viviane Dubruille; Steven Le Gouill; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Beatrice Saulquin; Jean-Luc Harousseau; Philippe Moreau; Mohamad Mohty
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1531-7.
2009: Jean-Luc Harousseau; Hervé Avet-Loiseau; Michel Attal; Catherine Charbonnel; Frederic Garban; Cyrille Hulin; Mauricette Michallet; Thierry Facon; Laurent Garderet; Gérald Marit; Nicolas Ketterer; Thierry Lamy; Laurent Voillat; françois guilhot; Chantal Doyen; Claire Mathiot; Philippe Moreau
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(34):5720-6.
2009: Jean-Luc Harousseau
Integrating novel therapies in the transplant paradigm.
Cancer journal (Sudbury, Mass.) 2009;15(6):479-84.
2009: Dan T Vogl; Edward A Stadtmauer; Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Thierry Facon; Jean-Luc Harousseau; Anthony Boral; Rachel Neuwirth; Kenneth C Anderson
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma.
British journal of haematology 2009;147(4):531-4.
2009: P Chevallier; M Labopin; A Nagler; P Ljungman; L F Verdonck; L Volin; A R Zander; J Finke; G Socie; C Cordonnier; Jean-Luc Harousseau; M Mohty; V Rocha
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT.
Bone marrow transplantation 2009;44(9):589-94.
2009: E Brissot; P Chevallier; T Guillaume; J Delaunay; S Ayari; V Dubruille; Steven Le Gouill; B Mahe; Thomas Gastinne; N Blin; B Saulquin; G Flandrois; A Devys; V Stocco; A Cesbron; F Dehaut; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
Bone marrow transplantation 2009;44(9):613-5.
2009: Jean-Luc Harousseau; Michel Attal; Herve Avet-Loiseau
The role of complete response in multiple myeloma.
Blood 2009;114(15):3139-46.
2009: Jean-Luc Harousseau
Hematopoietic stem cell transplantation in multiple myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(9):961-70.
2009: Sergio Giralt; E A Stadtmauer; Jean-Luc Harousseau; Antonio Palumbo; W Bensinger; R L Comenzo; S Kumar; N C Munshi; A Dispenzieri; R Kyle; G Merlini; J San Miguel; Heinz Ludwig; R Hajek; Sundar Jagannath; J Blade; Sagar Lonial; M A Dimopoulos; H Einsele; Bart Barlogie; Kenneth C Anderson; M Gertz; M Attal; P Tosi; Pieter Sonneveld; Mario Boccadoro; G Morgan; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; Wesley Chen; K Shimizu; R Powles; Paul G Richardson; R Niesvizky; S V Rajkumar; B G M Durie
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
Leukemia 2009;23(10):1904-12.
2009: Hervé Avet-Loiseau; Cheng Li; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Jean-Luc Harousseau; Michel Attal; Gerald Marit; Claire Mathiot; Thierry Facon; Philippe Moreau; Kenneth C Anderson; Loïc Campion; Nikhil C Munshi; Stéphane Minvielle
Prognostic significance of copy-number alterations in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4585-90.
2009: Bruno Cassinat; Stéphane de Botton; Charikleia Kelaidi; Lionel Ades; Fabien Zassadowski; Isabelle Guillemot; Marie-Helene Schlageter; Emmanuel Raffoux; Jean-Luc Harousseau; Ollivier Legrand; Martine Escoffre-Barbe; Oumedaly Reman; Martine Gardembas; Chantal Himberlin; Jean Yves Cahn; Denis Guyotat; Didier Bouscary; Anne Parry; Philippe Rousselot; Andre Baruchel; Hervé Dombret; Sylvie Chevret; Pierre Fenaux; Christine Chomienne
When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
Leukemia research 2009;33(9):1178-82.
2009: Shaji Kumar; Sergio Giralt; Edward A Stadtmauer; Jean-Luc Harousseau; Antonio Palumbo; William Bensinger; Raymond Comenzo; Suzanne Lentzsch; Nikhil Munshi; Ruben Niesvizky; Jesús San Miguel; Heinz Ludwig; Leif Bergsagel; Joan Blade; Sagar Lonial; Kenneth C Anderson; Patrizia Tosi; Pieter Sonneveld; Orhan Sezer; David H Vesole; Michele Cavo; Hermann Einsele; Paul G Richardson; Brian G M Durie; S Vincent Rajkumar
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
Blood 2009;114(9):1729-35.
2009: Charalampia Kyriakou; Carmen Canals; Jürgen Finke; Guido Kobbe; Jean-Luc Harousseau; Hans-Jochem Kolb; Nicolas Novitzky; Anthony H Goldstone; Anna Sureda; Norbert Schmitz
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3951-8.
2009: Jean-Luc Harousseau; Giovanni Martinelli; Wieslaw W Jedrzejczak; Joseph M Brandwein; Dominique Bordessoule; Tamas Masszi; Gert Ossenkoppele; Julia A Alexeeva; Gernot Beutel; Johan Maertens; Maria-Belen Vidriales; Hervé Dombret; Xavier Thomas; Alan K Burnett; Tadeusz Robak; Nuriet K Khuageva; Anatoly K Golenkov; Elena Tothova; Lars Mollgard; Youn C Park; Annick Bessems; Peter De Porre; Angela J Howes
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
Blood 2009;114(6):1166-73.
2009: Patrice Chevallier; Mathilde Hunault-Berger; Fabrice Larosa; Charles Dauriac; Richard Garand; Jean-Luc Harousseau
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial.
Leukemia research 2009;33(8):1124-6.
2009: Jean-Luc Harousseau; Philippe Moreau
Autologous hematopoietic stem-cell transplantation for multiple myeloma.
The New England journal of medicine 2009;360(25):2645-54.
2009: Mohamad Mohty; Vanderson Rocha; Patrice Chevallier; Jean-Luc Harousseau; Arnon Nagler
Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later.
Current opinion in oncology 2009;21 Suppl 1():S1.
2009: Jean-Luc Harousseau; M Dreyling
Multiple myeloma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():97-9.
2009: Michel Attal; Jean-Luc Harousseau
The role of high-dose therapy with autologous stem cell support in the era of novel agents.
Seminars in hematology 2009;46(2):127-32.
2009: P Chevallier; N Robillard; G Houille; S Ayari; T Guillaume; J Delaunay; Jean-Luc Harousseau; H Avet-Loiseau; M Mohty; R Garand
Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases.
Leukemia 2009;23(4):806-7.
2009: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Anthony Boral; Dixie Esseltine; Patrick Y Wen; Anthony A Amato; Kenneth C Anderson; Jesus San Miguel
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
British journal of haematology 2009;144(6):895-903.
2009: Antonio Palumbo; Meletios Dimopoulos; Jesus San Miguel; Jean-Luc Harousseau; Michel Attal; Mohamad Hussein; Stefan Knop; Heinz Ludwig; Marie von Lilienfeld-Toal; Pieter Sonneveld
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.
Blood reviews 2009;23(2):87-93.
2009: Pierre Peterlin; Thomas Gastinne; Philippe Moreau; Jean-Luc Harousseau; Steven Le Gouill
High-dose chemotherapy followed by autologous stem-cell transplantation in liver-transplanted multiple myeloma patients: a report of two cases.
Transplantation 2009;87(4):617-8.
2009: A Dispenzieri; R Kyle; G Merlini; J S Miguel; Heinz Ludwig; R Hajek; Antonio Palumbo; Sundar Jagannath; J Blade; Sagar Lonial; M Dimopoulos; R Comenzo; H Einsele; Bart Barlogie; Kenneth C Anderson; M Gertz; Jean-Luc Harousseau; M Attal; P Tosi; Pieter Sonneveld; Mario Boccadoro; G Morgan; Paul G Richardson; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; W Chen; K Shimizu; R Powles; S V Rajkumar; B G M Durie
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Leukemia 2009;23(2):215-24.
2009: Celso Rodrigues; Guillermo Sanz; Claudio G Brunstein; Jaime Sanz; John E Wagner; Marc Renaud; Marcos de Lima; Mitchell S Cairo; Sabine Fürst; Bernard Rio; Christopher Dalley; Enric Carreras; Jean-Luc Harousseau; Mohamad Mohty; Denis Taveira; Peter Dreger; Anna Sureda; Eliane Gluckman; Vanderson Rocha
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):256-63.
2009: Philippe Fagnoni; Noel Milpied; Samuel Limat; Eric DECONINCK; Virginie Nerich; Charles Foussard; Philippe Colombat; Jean-Luc Harousseau; Marie-Christine Woronoff-Lemsi
Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphoma.
PharmacoEconomics 2009;27(1):55-68.
2008: Joan Bladé; Pieter Sonneveld; Jesús F San Miguel; Heather J Sutherland; Roman Hajek; Arnon Nagler; Andrew Spencer; Tadeusz Robak; M Teresa Cibeira; Sen H Zhuang; Jean-Luc Harousseau; Robert Z Orlowski
Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment.
Clinical lymphoma & myeloma 2008;8(6):352-5.
2008: Patrice Chevallier; Nelly Robillard; Sameh Ayari; Thierry Guillaume; Jacques Delaunay; Francoise Mechinaud; Herve Avet-Loiseau; Mohamad Mohty; Jean-Luc Harousseau; Richard Garand
Persistence of CD33 expression at relapse in CD33(+) acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease.
British journal of haematology 2008;143(5):744-6.
2008: Philippe Moreau; Valerie Coiteux; Cyrille Hulin; Xavier Leleu; Helgi van de Velde; Milin Acharya; Jean-Luc Harousseau
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma.
Haematologica 2008;93(12):1908-11.
2008: Patrice Chevallier; Jacques Delaunay; Pascal Turlure; Arnaud Pigneux; Mathilde Hunault; Richard Garand; Thierry Guillaume; Hervé Avet-Loiseau; Nathalia Dmytruk; Stephane Girault; Noël Milpied; Norbert Ifrah; Mohamad Mohty; Jean-Luc Harousseau
Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5192-7.
2008: Philippe Moreau; Frédéric Garban; Michel Attal; Mauricette Michallet; Gérald Marit; Cyrille Hulin; Lotfi Benboubker; Chantal Doyen; Mohamad Mohty; Ibrahim Yakoub-Agha; Serge Leyvraz; Philippe Casassus; Hervé Avet-Loiseau; Laurent Garderet; Claire Mathiot; Jean-Luc Harousseau
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.
Blood 2008;112(9):3914-5.
2008: X Cahu; M Mohty; C Faucher; P Chevalier; N Vey; J El-Cheikh; T Guillaume; S Furst; J Delaunay; S Ayari; P Moreau; J A Gastaut; Jean-Luc Harousseau; D Blaise
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.
Bone marrow transplantation 2008;42(10):689-91.
2008: Patrice Chevallier; Mohamad Mohty; Bruno Lioure; Gerard Michel; Nathalie Contentin; Eric DECONINCK; Pierre Bordigoni; Jean-Paul Vernant; Mathilde Hunault; Stéphane Vigouroux; Didier Blaise; Reza Tabrizi; Agnes Buzyn; Gerard Socie; Mauricette Michallet; Christelle Volteau; Jean-Luc Harousseau
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4940-3.
2008: Asher Chanan-Khan; Pieter Sonneveld; Michael W Schuster; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Rachel Neuwirth; Kenneth C Anderson; Paul G Richardson
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4784-90.
2008: Olivier Decaux; Laurence Lodé; Florence Magrangeas; Catherine Charbonnel; Wilfried Gouraud; Pascal Jézéquel; Michel Attal; Jean-Luc Harousseau; Philippe Moreau; Régis Bataille; Loïc Campion; Hervé Avet-Loiseau; Stéphane Minvielle
Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4798-805.
2008: Sagar Lonial; Paul G Richardson; Jesús San Miguel; Pieter Sonneveld; Michael W Schuster; Joan Bladé; Jamie Cavenagh; S Vincent Rajkumar; Andrzej J Jakubowiak; Dixie Esseltine; Kenneth C Anderson; Jean-Luc Harousseau
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
British journal of haematology 2008;143(2):222-9.
2008: Ruben Niesvizky; Paul G Richardson; S Vincent Rajkumar; Morton Coleman; Laura Rosiñol; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Anthony L Boral; Dixie Esseltine; Kenneth C Anderson; Joan Bladé
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.
British journal of haematology 2008;143(1):46-53.
2008: Jean-Luc Harousseau
Autologous transplantation for multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 7():vii128-33.
2008: Patrice Chevallier; Beatrice Mahe; Richard Garand; Pascaline Talmant; Jean-Luc Harousseau; Jacques Delaunay
Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression.
International journal of hematology 2008;88(2):209-11.
2008: André Tichelli; Jakob Passweg; Dorota Wójcik; Alicia Rovó; Jean-Luc Harousseau; Tamas Masszi; Axel Zander; Albert Békássy; Charles Crawley; mutlu arat; Simona Sica; Patrick Lutz; Gérard Socié
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica 2008;93(8):1203-10.
2008: Patrice Chevallier; Cyrille Touzeau; Sameh Ayari; Thierry Guillaume; Jean-Luc Harousseau; Jacques Delaunay
Re-administration of a combination of chemotherapy + Gemtuzumab at relapse in CD33+ AML patient allows to second remission and is feasible without extra toxicity.
Leukemia research 2008;32(8):1321-2.
2008: Jean-Luc Harousseau
New treatments in multiple myeloma: beyond optimal treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 5():v68-70.
2008: Norbert-Claude Gorin; Myriam Labopin; Francesco Frassoni; Noel Milpied; Michel Attal; Didier Blaise; Giovanna Meloni; Anna P Iori; Mauricette Michallet; Roel Willemze; Eric Deconninck; Jean-Luc Harousseau; Emmanuelle Polge; Vanderson Rocha
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3183-8.
2008: Jean-Luc Harousseau
Maintenance treatment in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 4():iv54-5.
2008: Jesús San Miguel; Jean-Luc Harousseau; Douglas Joshua; Kenneth C Anderson
Individualizing treatment of patients with myeloma in the era of novel agents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2761-6.
2008: Patrice Chevallier; Chadi Al Nawakil; Stephane Vigouroux; Pascaline Talmant; Jean-Luc Harousseau; Richard Garand
Two cases of acute lymphoblastic leukaemia following acute myeloid leukaemia.
Leukemia research 2008;32(6):1001-3.
2008: Jean-Luc Harousseau; M Dreyling
Multiple myeloma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 2():ii55-7.
2008: Celine Bressollette-Bodin; A Claver; DAVID BOUTOLLEAU; P Chevallier; T Guillaume; T Gastinne; P Moreau; Jean-Luc Harousseau; B M Imbert-Marcille; S Le Gouill
Surgical treatment of a foscavir-resistant atypical Cytomegalovirus pneumonia in an allogeneic stem cell transplant recipient.
Haematologica 2008;93(5):e39-41.
2008: N Blin; F Méchinaud; P Talmant; R Garand; P Boutard; N Dastugue; E A McIntyre; Jean-Luc Harousseau; H Avet-Loiseau
Mature B-cell lymphoblastic leukemia with MLL rearrangement: an uncommon and distinct subset of childhood acute leukemia.
Leukemia 2008;22(5):1056-9.
2008: Heinz Ludwig; Brian G M Durie; Vanessa Bolejack; Ingemar Turesson; Robert A Kyle; Joan Blade; Rafael Fonseca; Meletios Dimopoulos; Kazuyuki Shimizu; Jesus San Miguel; Jan Westin; Jean-Luc Harousseau; Meral Beksac; Mario Boccadoro; Antonio Palumbo; Bart Barlogie; Chaim Shustik; Michele Cavo; Philip R Greipp; Douglas Joshua; Michel Attal; Pieter Sonneveld; John Crowley
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.
Blood 2008;111(8):4039-47.
2008: Antonio Palumbo; Thierry Facon; Pieter Sonneveld; Joan Bladè; Massimo Offidani; Francesca Gay; Philippe Moreau; Anders Waage; Andrew Spencer; Heinz Ludwig; Mario Boccadoro; Jean-Luc Harousseau
Thalidomide for treatment of multiple myeloma: 10 years later.
Blood 2008;111(8):3968-77.
2008: Mitch Raponi; Jean-Luc Harousseau
Development of genomic markers that predict response to molecularly targeted antileukemic therapy.
Expert opinion on medical diagnostics 2008;2(4):361-72.
2008: Pieter Sonneveld; Roman Hajek; Arnon Nagler; Andrew Spencer; Joan Bladé; Tadeusz Robak; Sen H Zhuang; Jean-Luc Harousseau; Robert Z Orlowski
Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.
Cancer 2008;112(7):1529-37.
2008: Jesús F San Miguel; Paul G Richardson; Pieter Sonneveld; M W Schuster; David Irwin; E A Stadtmauer; T Facon; Jean-Luc Harousseau; D Ben-Yehuda; Sagar Lonial; H Goldschmidt; D Reece; Joan Bladé; Mario Boccadoro; J D Cavenagh; R Neuwirth; A L Boral; Dixie Esseltine; Kenneth C Anderson
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.
Leukemia 2008;22(4):842-9.
2008: Benjamin Terrier; Arnaud Jaccard; Jean-Luc Harousseau; Richard Delarue; Olivier Tournilhac; Mathilde Hunault-Berger; Mohamed Hamidou; Jacques Dantal; Marc Bernard; Bernard Grosbois; Pierre Morel; Valérie Coiteux; Olivier Gisserot; Philippe Rodon; Arnaud Hot; Caroline Elie; Véronique Leblond; Jean-Paul Fermand; Fadi Fakhouri
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients.
Medicine 2008;87(2):99-109.
2008: Caroline Bodet-Milin; Françoise Kraeber-Bodéré; Benoît Dupas; Franck Morschhauser; Thomas Gastinne; Steven Le Gouill; Loïc Campion; Jean-Luc Harousseau; William A Wegener; David M Goldenberg; Damien Huglo
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
Haematologica 2008;93(3):390-7.
2008: Pierre-Joseph Royer; Gwenola Bougras; Frédéric Ebstein; Lucie LEVEQUE; Séverine Tanguy-Royer; Thomas Simon; Nadine Juge-Morineau; Patrice Chevallier; Jean-Luc Harousseau; Marc Gregoire
Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
Experimental hematology 2008;36(3):329-39.
2008: mitch raponi; Jeffrey E Lancet; Hongtao Fan; Lesley Dossey; Grace Lee; Ivana Gojo; Eric J Feldman; Jason Gotlib; Lawrence E Morris; Peter L Greenberg; John J Wright; Jean-Luc Harousseau; Bob Löwenberg; Richard M Stone; Peter De Porre; Yixin Wang; Judith E Karp
A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia.
Blood 2008;111(5):2589-96.
2008: Régis Bataille; Catherine Pellat-Deceunynck; Nelly Robillard; Hervé Avet-Loiseau; Jean-Luc Harousseau; Philippe Moreau
CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis.
Leukemia research 2008;32(3):379-82.
2008: Antonio Palumbo; S V Rajkumar; M A Dimopoulos; Paul G Richardson; J San Miguel; Bart Barlogie; Jean-Luc Harousseau; Jeffrey A Zonder; M Cavo; M Zangari; M Attal; A Belch; S Knop; D Joshua; O Sezer; Heinz Ludwig; D Vesole; J Bladé; R Kyle; J Westin; D Weber; S Bringhen; R Niesvizky; A Waage; M von Lilienfeld-Toal; Sagar Lonial; G J Morgan; Robert Z Orlowski; K Shimizu; Kenneth C Anderson; Mario Boccadoro; B G Durie; Pieter Sonneveld; M A Hussein
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Leukemia 2008;22(2):414-23.
2008: klaus podar; S L Gouill; J Zhang; J T Opferman; E Zorn; Yu-Tzu Tai; Teru Hideshima; M Amiot; Dharminder Chauhan; Jean-Luc Harousseau; Kenneth C Anderson
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
Oncogene 2008;27(6):721-31.
2008: Jean-Luc Harousseau
Induction therapy in multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2008;():306-12.
2007: Michel Attal; Jean-Luc Harousseau
Role of autologous stem-cell transplantation in multiple myeloma.
Best practice & research. Clinical haematology 2007;20(4):747-59.
2007: Jean-Luc Harousseau
New insights into the biology and advances in the management of multiple myeloma.
Best practice & research. Clinical haematology 2007;20(4):569-70.
2007: Mathilde Hunault; Malgorzata Truchan-Graczyk; Denis Caillot; Jean-Luc Harousseau; Serge Bologna; Chantal Himberlin; Denis Guyotat; Christian Berthou; Philippe Casassus; Laurence Baranger; marie bene; Norbert Ifrah; Emmanuel Gyan
Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
Haematologica 2007;92(12):1623-30.
2007: Jean-Luc Harousseau
Role of stem cell transplantation.
Hematology/oncology clinics of North America 2007;21(6):1157-74, x.
2007: B Sirohi; R Powles; Jean-Luc Harousseau; Kenneth C Anderson
The evolving background for high-dose treatment for myeloma.
Bone marrow transplantation 2007;40(12):1097-100.
2007: Jean-Luc Harousseau
The allogeneic dilemma.
Bone marrow transplantation 2007;40(12):1123-8.
2007: Meletios A Dimopoulos; Andrew Spencer; Michael Attal; H Miles Prince; Jean-Luc Harousseau; Anna Dmoszynska; Jesus San Miguel; Andrzej Hellmann; Thierry Facon; Robin Foà; Alessandro Corso; Zvenyslava Masliak; Marta Olesnyckyj; Zhinuan Yu; John Patin; Jerome B Zeldis; Robert D Knight
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.
The New England journal of medicine 2007;357(21):2123-32.
2007: Paul G Richardson; Pieter Sonneveld; Michael Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Jesus San Miguel; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Melissa Alsina; S Vincent Rajkumar; Martha Lacy; Andrzej J Jakubowiak; William Dalton; Anthony Boral; Dixie Esseltine; David P Schenkein; Kenneth C Anderson
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.
Blood 2007;110(10):3557-60.
2007: Thierry Facon; Jean-Yves Mary; Cyrille Hulin; Lotfi Benboubker; Michel Attal; Brigitte Pegourie; Marc Renaud; Jean-Luc Harousseau; Gaëlle Guillerm; Carine Chaleteix; Mamoun Dib; Laurent Voillat; Hervé Maisonneuve; Jacques Troncy; Véronique Dorvaux; Mathieu Monconduit; Claude Martin; Philippe Casassus; Jérôme Jaubert; Henry Jardel; Chantal Doyen; Brigitte Kolb; Bruno Anglaret; Bernard Grosbois; Ibrahim Yakoub-Agha; Claire Mathiot; Hervé Avet-Loiseau
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial.
Lancet 2007;370(9594):1209-18.
2007: Steven Le Gouill; Pascaline Talmant; Cyrille Touzeau; Anne Moreau; Richard Garand; Nadine Juge-Morineau; Fanny Gaillard; Thomas Gastinne; Noël Milpied; Philippe Moreau; Jean-Luc Harousseau; Hervé Avet-Loiseau
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Haematologica 2007;92(10):1335-42.
2007: Thomas Gastinne; Xavier Leleu; Alain Duhamel; Anne-Sophie Moreau; Genevieve Franck; Joris Andrieux; Jean-Luc Lai; Valérie Coiteux; Ibrahim Yakoub-Agha; Francis Bauters; Jean-Luc Harousseau; Marc Zandecki; Thierry Facon
Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
European journal of haematology 2007;79(4):297-304.
2007: Robert Z Orlowski; Arnon Nagler; Pieter Sonneveld; Joan Bladé; Roman Hajek; Andrew Spencer; Jesús San Miguel; Tadeusz Robak; Anna Dmoszynska; Noemi Horvath; Ivan Spicka; Heather J Sutherland; Alexander N Suvorov; Sen H Zhuang; Trilok Parekh; Liang Xiu; Zhilong Yuan; Wayne Rackoff; Jean-Luc Harousseau
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3892-901.
2007: Philippe Moreau; Michel Attal; Frédéric Garban; Cyrille Hulin; Thierry Facon; Gérald Marit; Mauricette Michallet; Chantal Doyen; S Leyvraz; Mohamad Mohty; Marc Wetterwald; Claire Mathiot; Denis Caillot; Christian Berthou; Lotfi Benboubker; Laurent Garderet; Carine Chaleteix; Catherine Traullé; Jean-Gabriel Fuzibet; Jérôme Jaubert; Thierry Lamy; Philippe Casassus; M Dib; B Kolb; Véronique Dorvaux; Bernard Grosbois; Ibrahim Yakoub-Agha; Jean-Luc Harousseau; Hervé Avet-Loiseau
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.
Leukemia 2007;21(9):2020-4.
2007: Jean-Luc Harousseau
Farnesyltransferase inihibitors in hematologic malignancies.
Blood reviews 2007;21(4):173-82.
2007: Philippe Moreau; Jean-Luc Harousseau; Michel Attal
Allografting or autografting for myeloma.
The New England journal of medicine 2007;356(25):2646-8; author reply 2646-8.
2007: Jean-Luc Harousseau; Jeffrey E Lancet; Josy Reiffers; Bob Lowenberg; Xavier Thomas; Francoise Huguet; Pierre Fenaux; Steven Zhang; Wayne Rackoff; Peter De Porre; Richard Stone
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.
Blood 2007;109(12):5151-6.
2007: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Jesús F San Miguel; Jamie Cavenagh; Kenneth C Anderson
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
British journal of haematology 2007;137(5):429-35.
2007: Hervé Avet-Loiseau; Michel Attal; Philippe Moreau; Catherine Charbonnel; Frédéric Garban; Cyrille Hulin; Serge Leyvraz; Mauricette Michallet; Ibrahim Yakoub-Agha; Laurent Garderet; Gérald Marit; Lucienne Michaux; Laurent Voillat; Marc Renaud; Bernard Grosbois; Gaelle Guillerm; Lotfi Benboubker; Mathieu Monconduit; Catherine Thieblemont; Philippe Casassus; Denis Caillot; Anne-Marie Stoppa; Jean-Jacques Sotto; Marc Wetterwald; Charles Dumontet; Jean-Gabriel Fuzibet; Isabelle Azais; Véronique Dorvaux; Marc Zandecki; Régis Bataille; Stéphane Minvielle; Jean-Luc Harousseau; Thierry Facon; Claire Mathiot
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.
Blood 2007;109(8):3489-95.
2007: mitch raponi; Jean-Luc Harousseau; Jeffrey E Lancet; Bob Löwenberg; Richard Stone; Yi Zhang; Wayne Rackoff; Yixin Wang; David Atkins
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2254-60.
2007: Philippe Moreau; Laurent Voillat; L Benboukher; Claire Mathiot; Charles Dumontet; Nelly Robillard; O Hérault; Francine Garnache; Richard Garand; N Varoqueaux; Hervé Avet-Loiseau; Jean-Luc Harousseau; R Bataille
Rituximab in CD20 positive multiple myeloma.
Leukemia 2007;21(4):835-6.
2007: Jean-Pierre Armand; Alan K Burnett; Johannes Drach; Jean-Luc Harousseau; Bob Löwenberg; Jesús San Miguel
The emerging role of targeted therapy for hematologic malignancies: update on bortezomib and tipifarnib.
The oncologist 2007;12(3):281-90.
2007: Jean-Luc Harousseau; Philippe Moreau
Role of bone marrow transplantation in the disease pathway of myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(2):163-9.
2007: Michel Attal; Philippe Moreau; Hervé Avet-Loiseau; Jean-Luc Harousseau
Stem cell transplantation in multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():311-6.
2007: Cyrille Touzeau; Catherine Pellat-Deceunynck; Thomas Gastinne; F Accard; G Jego; Hervé Avet-Loiseau; Nelly Robillard; Jean-Luc Harousseau; Régis Bataille; Philippe Moreau
Reactive plasmacytoses can mimick plasma cell leukemia: therapeutical implications.
Leukemia & lymphoma 2007;48(1):207-8.
2007: Sundar Jagannath; Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; J M Cowan; Kenneth C Anderson
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials.
Leukemia 2007;21(1):151-7.
2006: Michel Attal; Jean-Luc Harousseau; Serge Leyvraz; Chantal Doyen; Cyrille Hulin; Lotfi Benboubker; Ibrahim Yakoub-Agha; Jean-Henri Bourhis; Laurent Garderet; Brigitte Pegourie; Charles Dumontet; Marc Renaud; Laurent Voillat; Christian Berthou; Gérald Marit; Mathieu Monconduit; Denis Caillot; Bernard Grobois; Hervé Avet-Loiseau; Philippe Moreau; Thierry Facon
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.
Blood 2006;108(10):3289-94.
2006: Jean-Luc Harousseau; Michel Attal; Xavier Leleu; Jacques Troncy; Brigitte Pegourie; Anne-Marie Stoppa; Cyrille Hulin; Lotfi Benboubker; Jean-Gabriel Fuzibet; Marc Renaud; Philippe Moreau; Hervé Avet-Loiseau
Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.
Haematologica 2006;91(11):1498-505.
2006: Solène Querellou; Frédéric Valette; Caroline Bodet-Milin; Aurore Oudoux; Thomas Carlier; Jean-Luc Harousseau; Jean-François Chatal; Olivier Couturier
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Annals of hematology 2006;85(11):759-67.
2006: Jean-Luc Harousseau
Thalidomide in multiple myeloma: past, present and future.
Future oncology (London, England) 2006;2(5):577-89.
2006: Bart Barlogie; Guido Tricot; Frits van Rhee; Edgardo Angtuaco; Ron Walker; Joshua Epstein; John D Shaughnessy; Sundar Jagannath; Vanessa Bolejack; Jennifer Gurley; Antje Hoering; David H Vesole; Raman Desikan; David Siegel; Jayesh Mehta; shashank singhal; Nikhil C Munshi; Madhav V Dhodapkar; Bonnie Jenkins; Michel Attal; Jean-Luc Harousseau; John Crowley
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.
British journal of haematology 2006;135(2):158-64.
2006: Jean-Luc Harousseau
[A cure for multiple myeloma?].
Presse médicale (Paris, France : 1983) 2006;35(9 Pt 2):1288-90.
2006: Régis Bataille; Gaëtan Jégo; Nelly Robillard; Sophie Barillé-Nion; Jean-Luc Harousseau; Philippe Moreau; Martine Amiot; Catherine Pellat-Deceunynck
The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.
Haematologica 2006;91(9):1234-40.
2006: B G M Durie; Jean-Luc Harousseau; J S Miguel; J Bladé; Bart Barlogie; Kenneth C Anderson; M Gertz; M Dimopoulos; J Westin; Pieter Sonneveld; Heinz Ludwig; G Gahrton; M Beksac; J Crowley; A Belch; M Boccadaro; M Cavo; I Turesson; D Joshua; D Vesole; R Kyle; R Alexanian; Guido Tricot; M Attal; G Merlini; R Powles; Paul G Richardson; K Shimizu; P Tosi; G Morgan; S V Rajkumar
International uniform response criteria for multiple myeloma.
Leukemia 2006;20(9):1467-73.
2006: Emmanuelle Menoret; Patricia Gomez-Bougie; Alexandrine Geffroy-Luseau; Sylvanne Daniels; Philippe Moreau; Steven Le Gouill; Jean-Luc Harousseau; Régis Bataille; Martine Amiot; Catherine Pellat-Deceunynck
Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.
Blood 2006;108(4):1346-52.
2006: Jean-Luc Harousseau
[Jean Bernard].
Bulletin du cancer 2006;93(7):659.
2006: Stéphane Vigouroux; Odile Morin; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied
Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
Haematologica 2006;91(5):717-8.
2006: Frédéric Garban; Michel Attal; Mauricette Michallet; Cyrille Hulin; Jean-Henri Bourhis; Ibrahim Yakoub-Agha; Thierry Lamy; Gérald Marit; Frédéric Maloisel; Christian Berthou; Mamoun Dib; Denis Caillot; Bernard Deprijck; Nicolas Ketterer; Jean-Luc Harousseau; Jean-Jacques Sotto; Philippe Moreau
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma.
Blood 2006;107(9):3474-80.
2006: Thierry Facon; Jean-Yves Mary; Brigitte Pégourie; Michel Attal; Marc Renaud; Alain Sadoun; Laurent Voillat; Véronique Dorvaux; Cyrille Hulin; Gérard Lepeu; Jean-Luc Harousseau; Jean-Paul Eschard; Augustin Ferrant; Michel Blanc; Frédéric Maloisel; Hubert Orfeuvre; Jean-François Rossi; Isabelle Azaïs; Mathieu Monconduit; Philippe Collet; Bruno Anglaret; Ibrahim Yakoub-Agha; Marc Wetterwald; Houchingue Eghbali; Marie-Christine Vekemans; Hervé Maisonneuve; Jacques Troncy; Bernard Grosbois; Chantal Doyen; Antoine Thyss; Jérome Jaubert; Philippe Casassus; Béatrice Thielemans; Régis Bataille
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy.
Blood 2006;107(4):1292-8.
2006: Mario Dicato; Mario Boccadoro; Jamie Cavenagh; Jean-Luc Harousseau; Heinz Ludwig; Jesús San Miguel; Pieter Sonneveld
Management of multiple myeloma with bortezomib: experts review the data and debate the issues.
Oncology 2006;70(6):474-82.
2006: Philippe Moreau; Nelly Robillard; Gaétan Jégo; Catherine Pellat; Steven Le Gouill; Soraya Thoumi; Hervé Avet-Loiseau; Jean-Luc Harousseau; Régis Bataille
Lack of CD27 in myeloma delineates different presentation and outcome.
British journal of haematology 2006;132(2):168-70.
2006: Philippe Moreau; Cyrille Hullin; Frédéric Garban; Ibrahim Yakoub-Agha; Lotfi Benboubker; Michel Attal; Gérald Marit; Jean-Gabriel Fuzibet; Chantal Doyen; Laurent Voillat; Christian Berthou; Nicolas Ketterer; Philippe Casassus; Mathieu Monconduit; Mauricette Michallet; Albert Najman; Jean-Jacques Sotto; Régis Bataille; Jean-Luc Harousseau
Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol.
Blood 2006;107(1):397-403.
2005: Stéphane Vigouroux; Fanny Gaillard; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied
High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma.
Haematologica 2005;90(11):1580-2.
2005: Heinz Zwierzina; Stefan Suciu; Judith Loeffler-Ragg; R Neuwirtova; P Fenaux; M Beksac; Jean-Luc Harousseau; Volkmar Nuessler; J Cermak; G Solbu; Rein Willemze; Theo de Witte; Sergio Amadori
Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.
Leukemia 2005;19(11):1929-33.
2005: Jean-Luc Harousseau; Philippe Moreau
Evolving role of stem cell transplantation in multiple myeloma.
Clinical lymphoma & myeloma 2005;6(2):89-95.
2005: Patrice Chevallier; Virginie Roland; Béatrice Mahé; Nadine Juge-Morineau; Viviane Dubruille; Thierry Guillaume; Stéphane Vigouroux; Philippe Moreau; Noël Milpied; Richard Garand; Hervé Avet-Loiseau; Jean-Luc Harousseau
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leukemia research 2005;29(9):1003-7.
2005: Ugo De Giorgi; Giovanni Rosti; S Slavin; I Yaniv; Jean-Luc Harousseau; R Ladenstein; Taner Demirer; G Dini
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours.
British journal of cancer 2005;93(4):412-7.
2005: Pierre Sujobert; Valérie Bardet; Pascale Cornillet-Lefebvre; Joel S Hayflick; Nolwen Prie; Frédérique Verdier; Bart Vanhaesebroeck; Odile Muller; Florence Pesce; Norbert Ifrah; Mathilde Hunault-Berger; Christian Berthou; Bruno Villemagne; Eric Jourdan; Bruno Audhuy; Eric Solary; Brigitte Witz; Jean-Luc Harousseau; Chantal Himberlin; Thierry Lamy; Bruno Lioure; Jean-Yves Cahn; François Dreyfus; Patrick Mayeux; Catherine Lacombe; Didier Bouscary
Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia.
Blood 2005;106(3):1063-6.
2005: Soraya Wuillème-Toumi; Nelly Robillard; P Gomez; Philippe Moreau; Steven Le Gouill; Hervé Avet-Loiseau; Jean-Luc Harousseau; Martine Amiot; Régis Bataille
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.
Leukemia 2005;19(7):1248-52.
2005: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Jesús F San Miguel; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; William S Dalton; Anthony Boral; Dixie Esseltine; Jane B Porter; David P Schenkein; Kenneth C Anderson
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.
The New England journal of medicine 2005;352(24):2487-98.
2005: Philip R Greipp; Jesús San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Hervé Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan José Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
International staging system for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3412-20.
2005: Laure Denis; Katia Gagne; Brigitte Gueglio; Nolwenn Kerdudou; Noël Milpied; Philippe Simon; Gilles Follea; Marc Bonneville; Jean-Luc Harousseau; Jean-Denis Bignon
NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation.
Human immunology 2005;66(5):447-59.
2005: Régis Bataille; Nelly Robillard; Hervé Avet-Loiseau; Jean-Luc Harousseau; Philippe Moreau
CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity.
Haematologica 2005;90(5):706-7.
2005: Jean-Luc Harousseau
Stem cell transplantation in multiple myeloma (0, 1, or 2).
Current opinion in oncology 2005;17(2):93-8.
2005: Stéphane Vigouroux; Odile Morin; Philippe Moreau; Françoise Méchinaud; Nadine Morineau; Béatrice Mahé; Patrice Chevallier; Thierry Guillaume; Viviane Dubruille; Jean-Luc Harousseau; Noël Milpied
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(4):e35-7.
2005: S Wuilleme; Nelly Robillard; Laurence Lodé; Florence Magrangeas; H Beris; Jean-Luc Harousseau; J Proffitt; Stéphane Minvielle; Hervé Avet-Loiseau
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
Leukemia 2005;19(2):275-8.
2005: Jean-Luc Harousseau; Philippe Moreau; Michel Attal; Thierry Facon; Hervé Avet-Loiseau
Stem-cell transplantation in multiple myeloma.
Best practice & research. Clinical haematology 2005;18(4):603-18.
2004: Mathilde Hunault; Jean-Luc Harousseau; Martine Delain; Malgorzata Truchan-Graczyk; Jean-Yves Cahn; Francis Witz; Thierry Lamy; Bernard Pignon; Jean-Pierre Jouet; Reda Garidi; Denis Caillot; Christian Berthou; Denis Guyotat; Alain Sadoun; Jean-Jacques Sotto; Bruno Lioure; Philippe Casassus; Philippe Solal-Celigny; Laure Stalnikiewicz; Bruno Audhuy; Odile Blanchet; Laurence Baranger; marie bene; Norbert Ifrah
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.
Blood 2004;104(10):3028-37.
2004: Jean-Luc Harousseau
New strategies in transplantation therapy.
Oncology (Williston Park, N.Y.) 2004;18(13):1614-5, 1617.
2004: Patrice Chevallier; Nelly Robillard; Soraya Wuilleme-Toumi; Françoise Méchinaud; Jean-Luc Harousseau; Hervé Avet-Loiseau
Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.
Haematologica 2004;89(11):1399-401.
2004: Steven Le Gouill; klaus podar; Martine Amiot; Teru Hideshima; Dharminder Chauhan; Kenji Ishitsuka; Shaji Kumar; Noopur Raje; Paul G Richardson; Jean-Luc Harousseau; Kenneth C Anderson
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis.
Blood 2004;104(9):2886-92.
2004: Steven Le Gouill; klaus podar; Jean-Luc Harousseau; Kenneth C Anderson
Mcl-1 regulation and its role in multiple myeloma.
Cell cycle (Georgetown, Tex.) 2004;3(10):1259-62.
2004: Nicolas Blin; Nadine Morineau; Fanny Gaillard; Odile Morin; Noël Milpied; Jean-Luc Harousseau; Philippe Moreau
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2004;45(10):2161-3.
2004: David Khayat; Olivier Rixe; René Brunet; Alain Goupil; Roland Bugat; Jean-Luc Harousseau; Norbert Ifrah; Christian Puozzo
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design.
Cancer chemotherapy and pharmacology 2004;54(3):193-205.
2004: Florence Magrangeas; Marie-Laure Cormier; Géraldine Descamps; Nadège Gouy; Laurence Lodé; Marie-Paule Mellerin; Jean-Luc Harousseau; Régis Bataille; Stéphane Minvielle; Hervé Avet-Loiseau
Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level.
Blood 2004;103(10):3869-75.
2004: Philippe Moreau; Nelly Robillard; Hervé Avet-Loiseau; Danielle Pineau; Nadine Morineau; Noël Milpied; Jean-Luc Harousseau; Régis Bataille
Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.
Haematologica 2004;89(5):547-51.
2004: Noël Milpied; Eric DECONINCK; Fanny Gaillard; Vincent Delwail; Charles Foussard; Christian Berthou; Rémy Gressin; Virginie Lucas; Philippe Colombat; Jean-Luc Harousseau
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
The New England journal of medicine 2004;350(13):1287-95.
2004: Jean-Luc Harousseau; John Shaughnessy; Paul G Richardson
Multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():237-56.
2004: Jean-Luc Harousseau
Treatment of acute myeloid leukemia younger adults: the GOELAM experience.
Annals of hematology 2004;83 Suppl 1():S104-5.
2004: Francis Witz; Jean-Luc Harousseau; françois guilhot; Jean-Yves Cahn; Brigitte Witz; C Loos; M P Chevalier; O Guibon; Patrice Berthaud; Bruno Lioure
Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM data.
Annals of hematology 2004;83 Suppl 1():S55-7.
2003: Michel Attal; Jean-Luc Harousseau; Thierry Facon; françois guilhot; Chantal Doyen; Jean-Gabriel Fuzibet; Mathieu Monconduit; Cyrille Hulin; Denis Caillot; Reda Bouabdallah; Laurent Voillat; Jean-Jacques Sotto; Bernard Grosbois; Regis Bataille
Single versus double autologous stem-cell transplantation for multiple myeloma.
The New England journal of medicine 2003;349(26):2495-502.
2003: Richard Garand; Hervé Avet-Loiseau; F Accard; Philippe Moreau; Jean-Luc Harousseau; Régis Bataille
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.
Leukemia 2003;17(10):2032-5.
2003: Eric Solary; Bernard Drenou; Lydia Campos; Patricia de Crémoux; Francine Mugneret; Philippe Moreau; Bruno Lioure; Annie Falkenrodt; Brigitte Witz; Marc Bernard; Mathilde Hunault-Berger; Martine Delain; José Fernandes; Christiane Mounier; françois guilhot; Francine Garnache; Christian Berthou; Fawzi Kara-Slimane; Jean-Luc Harousseau
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia.
Blood 2003;102(4):1202-10.
2003: Peter Borchmann; Franck Morschhauser; Anne Parry; Roland Schnell; Jean-Luc Harousseau; Christian Gisselbrecht; Christian Rudolph; Martin Wilhelm; Hans Günther; Derigs Michael Pfreundschuh; Gabriella Camboni; Andreas Engert
Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas.
Haematologica 2003;88(8):888-94.
2003: Henri Wajcman; Josiane Bardakdjian-Michau; Jean Riou; Claude Préhu; Jean Kister; Véronique Baudin-Creuza; Danielle Promé; Suzy Richelme-David; Jean-Luc Harousseau; Frédéric Galactéros
Two new hemoglobin variants with increased oxygen affinity: Hb Nantes [beta34(B16)Val-->Leu] and Hb Vexin [beta116(G18)His-->Leu].
Hemoglobin 2003;27(3):191-9.
2003: Nelly Robillard; Hervé Avet-Loiseau; Richard Garand; Philippe Moreau; Danielle Pineau; Marie-Josée Rapp; Jean-Luc Harousseau; Régis Bataille
CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.
Blood 2003;102(3):1070-1.
2003: Jacques Delaunay; Norbert Vey; Thierry Leblanc; Pierre Fenaux; Françoise Rigal-Huguet; Francis Witz; Thierry Lamy; Anne Auvrignon; Didier Blaise; Arnaud Pigneux; Francine Mugneret; Christian Bastard; Nicole Dastugue; Jacqueline van den Akker; Denis Fière; Josy Reiffers; Sylvie Castaigne; Guy Leverger; Jean-Luc Harousseau; Hervé Dombret
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Blood 2003;102(2):462-9.
2003: Jean-Luc Harousseau
[Autograft of hematopoietic stem cells in multiple myeloma].
Presse médicale (Paris, France : 1983) 2003;32(24):1107.
2003: Florence Magrangeas; Valéry Nasser; Hervé Avet-Loiseau; Béatrice Loriod; Olivier Decaux; Samuel Granjeaud; François Bertucci; Daniel Birnbaum; Catherine Nguyen; Jean-Luc Harousseau; Régis Bataille; Rémi Houlgatte; Stéphane Minvielle
Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease.
Blood 2003;101(12):4998-5006.
2003: Jean-Luc Harousseau
Autologous stem cell transplantation in multiple myeloma: none, one, or two?
Current hematology reports 2003;2(3):171-2.
2003: Béatrice Mahé; Noël Milpied; Marie-Paule Mellerin; Philippe Moreau; Nadine Morineau; Magda Vigier; Jean-Luc Harousseau
PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
Bone marrow transplantation 2003;31(6):467-73.
2003: Hervé Avet-Loiseau; Richard Garand; Laurence Lodé; Jean-Luc Harousseau; Régis Bataille
Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants.
Blood 2003;101(4):1570-1.
2003: Jean-Jacques Body; Philip R Greipp; Robert E Coleman; Thierry Facon; Filip Geurs; Jean-Paul Fermand; Jean-Luc Harousseau; Allan Lipton; Xavier Mariette; Catherine D Williams; Arline Nakanishi; Donna L Holloway; Steven W Martin; Colin R Dunstan; Pirow J Bekker
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.
Cancer 2003;97(3 Suppl):887-92.
2003: Brian G M Durie; Robert A Kyle; Andrew Belch; William Bensinger; Joan Blade; Mario Boccadoro; J Anthony Child; Raymond Comenzo; Benjamin Djulbegovic; Dorotea Fantl; Gösta Gahrton; Jean-Luc Harousseau; Vania Hungria; Douglas Joshua; Heinz Ludwig; Jayesh Mehta; Angelina Rodrique Morales; Gareth Morgan; Amara Nouel; Martin Oken; Raymond Powles; David Roodman; Jesús San Miguel; Kazuyuki Shimizu; Seema Singhal; Bhawna Sirohi; Pieter Sonneveld; Guido Tricot; Brian Van Ness
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(6):379-98.
2003: Jean-Luc Harousseau
[Intensive treatment of multiple myeloma].
Bulletin de l'Académie nationale de médecine 2003;187(2):405-13; discussion 413-5.
2003: Jean-Luc Harousseau; Michel Attal
High-dose therapy in multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(3):163-70.
2003: Frédéric Maloisel; Lotfi Benboubker; Martine Gardembas; Bertrand Coiffier; Marine Divine; Catherine Sebban; Michel Blanc; Jean-François Abgrall; Pierre Lederlin; Jean-Luc Harousseau; A-M Blaise; Bernard Grosbois; P Morice; C Ghandour; S Castaigne
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
Leukemia 2003;17(1):45-51.
2002: Claude Linassier; Bernard Desablens; Thierry Lefrancq; Pierre-Yves Le Prise; Jean-Luc Harousseau; Claude Jacob; Christine Gandhour; Olivier Haillot; Virginie Lucas; Rémy Leloup; Martine Escoffre; Philippe Colombat; Stéphanie Tabuteau
Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
Clinical lymphoma 2002;3(3):167-72.
2002: Jean-Luc Harousseau; Michel Attal
The role of stem cell transplantation in multiple myeloma.
Blood reviews 2002;16(4):245-53.
2002: Jean-Luc Harousseau
Management of multiple myeloma.
Reviews in clinical and experimental hematology 2002;6(3):253-75.
2002: M Baudard; A Vincent; P Moreau; M F Kergueris; Jean-Luc Harousseau; N Milpied
Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients.
Bone marrow transplantation 2002;30(5):287-95.
2002: Philippe Moreau; R Misbahi; Noël Milpied; Nadine Morineau; Béatrice Mahé; Magda Vigier; Marie-Josée Rapp; Régis Bataille; Jean-Luc Harousseau
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
Leukemia 2002;16(9):1838-43.
2002: Steven Le Gouill; Catherine Pellat-Deceunynck; Jean-Luc Harousseau; Marie-Josée Rapp; Nelly Robillard; Régis Bataille; Martine Amiot
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells.
Leukemia 2002;16(9):1664-7.
2002: Philippe Moreau; Thierry Facon; Xavier Leleu; Nadine Morineau; Pauline Huyghe; Jean-Luc Harousseau; Régis Bataille; Hervé Avet-Loiseau
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.
Blood 2002;100(5):1579-83.
2002: Lisa Oliver; Fabienne Vavasseur; Beatrice Mahé; Pascale Perrin; Jean-Luc Harousseau; Khaled Meflah; François M Vallette
Assessment of caspase activity as a possible prognostic factor in acute myeloid leukaemia.
British journal of haematology 2002;118(2):434-7.
2002: Sophie Derenne; Brett P Monia; Nicholas Dean; Jennifer Taylor; Marie-Josée Rapp; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.
Blood 2002;100(1):194-9.
2002: Radek Spisek; Patrice Chevallier; Nadine Morineau; Noël Milpied; Hervé Avet-Loiseau; Jean-Luc Harousseau; Khaled Meflah; Marc Gregoire
Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
Cancer research 2002;62(10):2861-8.
2002: Stéphanie Nguyen; Thierry Leblanc; Pierre Fenaux; Francis Witz; Didier Blaise; Arnaud Pigneux; Xavier Thomas; Françoise Rigal-Huguet; Bruno Lioure; Anne Auvrignon; Denis Fière; Josy Reiffers; Sylvie Castaigne; Guy Leverger; Jean-Luc Harousseau; Gérard Socié; Hervé Dombret
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
Blood 2002;99(10):3517-23.
2002: Stéphane Vigouroux; Noël Milpied; J M Andrieu; P Colonna; Norbert Ifrah; Philippe Colombat; Bernard Desablens; Jean-François Abgrall; Philippe Casassus; françois guilhot; Josette Briere; Annick Le Mevel; Philippe Moreau; F Mechinaud; Béatrice Mahe; Nadine Morineau; Magda Vigier; Marie-Josée Rapp; Jean-Luc Harousseau
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.
Bone marrow transplantation 2002;29(10):833-42.
2002: Frédéric Maloisel; Agnès Guerci; Denis Guyotat; Norbert Ifrah; Mauricette Michallet; J Reiffers; G Tertain; Michel Blanc; Frédéric Bauduer; J Brière; Jean-François Abgrall; B Pegourie-Bandelier; Eric Solary; Nathalie Cambier; Diane Coso; Jean-Pierre Vilque; Martine Delain; Jean-Luc Harousseau; Philippe Rousselot; Karim Belhadj; P Morice; J Attal; M Chabin; C Chastang; Joëlle Guilhot; françois guilhot
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.
Leukemia 2002;16(4):573-80.
2002: Hervé Avet-Loiseau; Thierry Facon; Bernard Grosbois; Florence Magrangeas; Marie-Josée Rapp; Jean-Luc Harousseau; Stéphane Minvielle; Régis Bataille
Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.
Blood 2002;99(6):2185-91.
2002: Steven Le Gouill; Philippe Moreau; Nadine Morineau; Jean-Luc Harousseau; Noël Milpied
Tandem high-dose therapy followed by autologous stem-cell transplantation for refractory or relapsed high grade non-Hodgkin's lymphoma with poor prognosis factors: a prospective pilot study.
Haematologica 2002;87(3):333-4.
2002: Philippe Moreau; Thierry Facon; Michel Attal; Cyrille Hulin; Mauricette Michallet; Frédéric Maloisel; Jean-Jacques Sotto; françois guilhot; Gérald Marit; Chantal Doyen; Jérôme Jaubert; Jean-Gabriel Fuzibet; Sylvie François; Lotfi Benboubker; Mathieu Monconduit; Laurent Voillat; Margaret Macro; Christian Berthou; Véronique Dorvaux; Bernard Pignon; Bernard Rio; Thomas Matthes; Philippe Casassus; Denis Caillot; Norbert Najman; Bernard Grosbois; Régis Bataille; Jean-Luc Harousseau
Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.
Blood 2002;99(3):731-5.
2002: Kenneth C Anderson; John D Shaughnessy; Bart Barlogie; Jean-Luc Harousseau; David G Roodman
Multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():214-40.
2002: Jean-Luc Harousseau
High-dose therapy in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():49-54.
2002: Ibrahim Yakoub-Agha; Michel Attal; Charles Dumontet; Valérie Delannoy; Philippe Moreau; Christian Berthou; Thierry Lamy; Bernard Grosbois; Charly Dauriac; Véronique Dorvaux; Jacques-Olivier Bay; Mathieu Monconduit; Jean-Luc Harousseau; Corinne Duguet; Alain Duhamel; Thierry Facon
Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM).
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(4):185-92.
2002: Patrice Chevallier; Dominique Penther; Hervé Avet-Loiseau; Nelly Robillard; Norbert Ifrah; Béatrice Mahé; Mohamed Hamidou; Hervé Maisonneuve; Philippe Moreau; Henri Jardel; Jean-Luc Harousseau; Régis Bataille; Richard Garand
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
British journal of haematology 2002;116(1):142-50.
2001: Theo de Witte; F Pikkemaat; J Hermans; Anja van Biezen; S Mackinnan; J Cornelissen; Alois Gratwohl; M Delforge; Arturo Iriondo; M Kuentz; Jean-Luc Harousseau; Axel A Fauser; Hannes Wandt; Volker Runde; Dietger Niederwieser; Jane Apperley
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation.
Leukemia 2001;15(12):1878-84.
2001: Hervé Avet-Loiseau; F Gerson; Florence Magrangeas; Stéphane Minvielle; Jean-Luc Harousseau; Régis Bataille
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Blood 2001;98(10):3082-6.
2001: Véronique Leblond; Vincent Lévy; Frédéric Maloisel; Bruno Cazin; Jean-Paul Fermand; Jean-Luc Harousseau; L Remenieras; Raphaël Porcher; Martine Gardembas; Gérald Marit; Eric DECONINCK; Bernard Desablens; françois guilhot; G Philippe; Aspasia Stamatoullas; O Guibon
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
Blood 2001;98(9):2640-4.
2001: M Attal; Jean-Luc Harousseau
[Autograft and multiple myeloma: experience of the Intergroupe Français du Myélome].
Bulletin du cancer 2001;88(9):888-92.
2001: Stéphane Bezieau; Marie-Claire Devilder; Hervé Avet-Loiseau; Marie-Paule Mellerin; D Puthier; Erwan Pennarun; Marie-Josée Rapp; Jean-Luc Harousseau; Jean-Paul Moisan; Régis Bataille
High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
Human mutation 2001;18(3):212-24.
2001: Vincent Lévy; Raphaël Porcher; Véronique Leblond; Jean-Paul Fermand; Bruno Cazin; Frédéric Maloisel; Jean-Luc Harousseau; L Remenieras; O Guibon; Sylvie Chevret
Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis.
Leukemia 2001;15(9):1466-70.
2001: X Tang; N Morineau; N Milpied; P Moreau; R Bataille; Jean-Luc Harousseau
[Autologous peripheral blood selected CD34+ cell transplantation in the treatment of multiple myeloma].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2001;22(7):370-3.
2001: M Attal; Jean-Luc Harousseau
Randomized trial experience of the Intergroupe Francophone du Myélome.
Seminars in hematology 2001;38(3):226-30.
2001: E Ninin; Noël Milpied; Philippe Moreau; B André-Richet; Nadine Morineau; Béatrice Mahé; Magda Vigier; B M Imbert; Odile Morin; Jean-Luc Harousseau; Hervé Richet
Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):41-7.
2001: C Schmitt; Y Perel; Jean-Luc Harousseau; S Lemerle; E Chwetzoff; Jean-Pierre Le Moing; Jean-Claude Levron
Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis.
Antimicrobial agents and chemotherapy 2001;45(5):1561-4.
2001: Thierry Facon; Hervé Avet-Loiseau; Gaëlle Guillerm; P Moreau; Frank Geneviève; Marc Zandecki; Jean-Luc Laï; Xavier Leleu; Jean-Pierre Jouet; Francis Bauters; Jean-Luc Harousseau; Régis Bataille; Jean-Yves Mary
Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy.
Blood 2001;97(6):1566-71.
2001: M C Woronoff-Lemsi; F Witz; P Arveux; J Y Cahn; Jean-Luc Harousseau
[Cost effectiveness of GM-CSF in the treatment of acute myeloblastic leukemia in aged patients: protocol of GOELAM Sa3].
Thérapie 2001;56(2):131-3.
2001: D Puthier; W Thabard; M Rapp; M Etrillard; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule.
British journal of haematology 2001;112(2):358-63.
2001: W S Dalton; P Leif Bergsagel; W Michael Kuehl; Kenneth C Anderson; Jean-Luc Harousseau
Multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2001;():157-77.
2001: O Thomas; Marc-André Mahé; Loïc Campion; S Bourdin; Noël Milpied; G Brunet; Albert Lisbona; Annick Le Mevel; Philippe Moreau; Jean-Luc Harousseau; JC Cuillière
Long-term complications of total body irradiation in adults.
International journal of radiation oncology, biology, physics 2001;49(1):125-31.
2000: Pauline Brice; D Simon; Reda Bouabdallah; C Bélanger; C Haïoun; C Thieblemont; Hervé Tilly; Jean-Luc Harousseau; Chantal Doyen; C Martin; Nicole Brousse; Philippe Solal-Céligny
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1585-90.
2000: Jean-Luc Harousseau
[Treatment of multiple myeloma].
Schweizerische medizinische Wochenschrift 2000;130(44):1649-55.
2000: Stéphane Vigouroux; Odile Morin; Noël Milpied; Béatrice Mahé; Marie-Josée Rapp; Jean-Luc Harousseau
[Cryptococcus neoformans infection in hematologic malignancies].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2000;21(11):955-60.
2000: Nadine Morineau; X W Tang; Philippe Moreau; Noël Milpied; Béatrice Mahé; Régis Bataille; Jean-Luc Harousseau
Lack of benefit of CD34+ cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single center study.
Leukemia 2000;14(10):1815-20.
2000: G Jego; Hervé Avet-Loiseau; Nelly Robillard; Philippe Moreau; Martine Amiot; Jean-Luc Harousseau; Catherine Pellat-Deceunynck; Régis Bataille
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF.
Leukemia research 2000;24(7):627-30.
2000: Jean-Luc Harousseau; A W Dekker; A Stamatoullas-Bastard; A Fassas; W Linkesch; J Gouveia; Robrecht De Bock; M Rovira; Wilfried Seifert; H Joosen; M Peeters; K De Beule
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Antimicrobial agents and chemotherapy 2000;44(7):1887-93.
2000: M Tiab; F Mechinaud; Jean-Luc Harousseau
Haemophagocytic syndrome associated with infections.
Baillière's best practice & research. Clinical haematology 2000;13(2):163-78.
2000: Jean-Luc Harousseau; R Zittoun; J Bonneterre; M Hedouin; J Ouvry
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
Bulletin du cancer 2000;87(6):491-7.
2000: P Moreau; Jean-Luc Harousseau; J Wijdenes; N Morineau; N Milpied; R Bataille
A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma.
British journal of haematology 2000;109(3):661-4.
2000: Marc-André Mahé; S Bourdin; A Le Pourhiet-Le Mevel; Philippe Moreau; Loïc Campion; Mohamed Hamidou; Noël Milpied; Anne Moreau; Fanny Gaillard; Jean-Luc Harousseau; JC Cuillière
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy.
International journal of radiation oncology, biology, physics 2000;47(3):735-8.
2000: Steven Le Gouill; Pascaline Talmant; Noël Milpied; A Daviet; M Ancelot; Philippe Moreau; Jean-Luc Harousseau; Régis Bataille; Hervé Avet-Loiseau
Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1533-8.
2000: Catherine Pellat-Deceunynck; Marie-Paule Mellerin; Nathalie Labarrière; G Jego; Agnès Moreau-Aubry; Jean-Luc Harousseau; Francine Jotereau; Régis Bataille
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
European journal of immunology 2000;30(3):803-9.
2000: Jean-Luc Harousseau; Brigitte Witz; Bruno Lioure; Mathilde Hunault-Berger; Bernard Desablens; Martine Delain; françois guilhot; P Y Le Prise; Jean-François Abgrall; Eric DECONINCK; Denis Guyotat; Jean-Pierre Vilque; Philippe Casassus; Olivier Tournilhac; Bruno Audhuy; Eric Solary
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):780-7.
2000: Ibrahim Yakoub-Agha; Philippe Moreau; S Leyvraz; Christian Berthou; C Payen; Charles Dumontet; Bernard Grosbois; P Beris; Corinne Duguet; Michel Attal; Jean-Luc Harousseau; Thierry Facon
Thalidomide in patients with advanced multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(3):186-9.
1999: Sophie Derenne; Martine Amiot; S Barillé; Madeleine Collette; Nelly Robillard; P Berthaud; Jean-Luc Harousseau; Régis Bataille
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(12):2048-56.
1999: S Barillé; Régis Bataille; Marie-Josée Rapp; Jean-Luc Harousseau; Martine Amiot
Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5723-8.
1999: Jean-Luc Harousseau
[Leukemias induced by anticancer chemotherapies].
Bulletin du cancer 1999;86(11):929-38.
1999: D Puthier; Sophie Derenne; S Barillé; Philippe Moreau; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
British journal of haematology 1999;107(2):392-5.
1999: Norbert Ifrah; Francis Witz; Jean-Pierre Jouet; Sylvie François; Thierry Lamy; Claude Linassier; Bernard Pignon; Christian Berthou; Denis Guyotat; Jean-Yves Cahn; Jean-Luc Harousseau
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
Cancer 1999;86(8):1496-505.
1999: Hervé Avet-Loiseau; JY Li; Nadine Morineau; Thierry Facon; Christophe Brigaudeau; Jean-Luc Harousseau; B Grosbois; Régis Bataille
Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.
Blood 1999;94(8):2583-9.
1999: W Thabard; S Barillé; Madeleine Collette; Jean-Luc Harousseau; Marie-Josée Rapp; Régis Bataille; Martine Amiot
Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2693-7.
1999: Reda Bouabdallah; François Lefrère; C Rose; P Chaïbi; Jean-Luc Harousseau; J P Vernant; Sylvie Castaigne; Frédéric Bauduer; J M Zini; Diane Coso; Bruno Varet; J Robert; Pierre Fenaux
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients.
Leukemia 1999;13(10):1491-6.
1999: Hervé Avet-Loiseau; C Godon; JY Li; A Daviet; Marie-Paule Mellerin; Pascaline Talmant; Jean-Luc Harousseau; Régis Bataille
Amplification of the 11q23 region in acute myeloid leukemia.
Genes, chromosomes & cancer 1999;26(2):166-70.
1999: Hervé Avet-Loiseau; Thierry Facon; A Daviet; C Godon; Marie-Josée Rapp; Jean-Luc Harousseau; Bernard Grosbois; Régis Bataille
14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
Cancer research 1999;59(18):4546-50.
1999: Hervé Avet-Loiseau; J Y Li; C Godon; Nadine Morineau; A Daviet; Jean-Luc Harousseau; T Facon; Régis Bataille
P53 deletion is not a frequent event in multiple myeloma.
British journal of haematology 1999;106(3):717-9.
1999: Thierry Facon; Jean-Luc Harousseau; Frédéric Maloisel; Michel Attal; Jesús Odriozola; Adrián Alegre; W Schroyens; Cyrille Hulin; Rik Schots; P Marin; françois guilhot; A Granena; Marc De Waele; Arnaud Pigneux; V Méresse; P Clark; J Reiffers
Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.
Blood 1999;94(4):1218-25.
1999: Didier Decaudin; Eric Lepage; Nicole Brousse; Pauline Brice; Jean-Luc Harousseau; Karim Belhadj; Hervé Tilly; L Michaux; S Chèze; Bertrand Coiffier; Philippe Solal-Céligny
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2499-505.
1999: S Barillé; W Thabard; Nelly Robillard; Philippe Moreau; Danielle Pineau; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
CD130 rather than CD126 expression is associated with disease activity in multiple myeloma.
British journal of haematology 1999;106(2):532-5.
1999: G Jego; Nelly Robillard; D Puthier; Martine Amiot; F Accard; Danielle Pineau; Jean-Luc Harousseau; Régis Bataille; Catherine Pellat-Deceunynck
Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells.
Blood 1999;94(2):701-12.
1999: Jean-Luc Harousseau
Optimizing peripheral blood progenitor cell autologous transplantation in multiple myeloma.
Haematologica 1999;84(6):548-53.
1999: Philippe Moreau; Noël Milpied; Béatrice Mahé; Nadine Juge-Morineau; Marie-Josée Rapp; Régis Bataille; Jean-Luc Harousseau
Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma.
Bone marrow transplantation 1999;23(10):1003-6.
1999: S L Le Gouill; N Morineau; M Miégeville; Noël Milpied; Jean-Luc Harousseau; P Moreau
[Pseudallescheria boydii osteoarthritis in a patient with acute lymphoblastic leukemia: a case report].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(5):434-8.
1999: JY Li; F Gaillard; A Moreau; Jean-Luc Harousseau; C Laboisse; Noël Milpied; Régis Bataille; Hervé Avet-Loiseau
Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization.
The American journal of pathology 1999;154(5):1449-52.
1999: M Attal; Jean-Luc Harousseau
Autologous peripheral blood progenitor cell transplantation for multiple myeloma.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):171-91.
1999: Noël Milpied; M Coste-Burel; F Accard; A Moreau; Philippe Moreau; Richard Garand; Jean-Luc Harousseau
Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
Bone marrow transplantation 1999;23(6):629-30.
1999: P Moreau; M Le Bonniec; Jean-Luc Harousseau
[High-dose melphalan in patients with multiple myeloma].
Bulletin du cancer 1999;86(3):283-8.
1999: Catherine Pellat-Deceunynck; G Jego; Jean-Luc Harousseau; H Vié; Régis Bataille
Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):705-9.
1999: Philippe Moreau; A Huynh; Thierry Facon; I Bouilly; J J Sotto; Laurence Legros; Noël Milpied; Michel Attal; R Bataille; Jean-Luc Harousseau
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)
Leukemia 1999;13(3):490-1.
1999: Jean-Luc Harousseau
Intensive therapy in multiple myeloma.
Pathologie-biologie 1999;47(2):203-9.
1999: D Puthier; Catherine Pellat-Deceunynck; S Barillé; Nelly Robillard; Marie-Josée Rapp; Nadine Juge-Morineau; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy.
Leukemia 1999;13(2):289-94.
1999: Hervé Avet-Loiseau; Christophe Brigaudeau; Nadine Morineau; Pascaline Talmant; J L Laï; A Daviet; JY Li; V Praloran; Marie-Josée Rapp; Jean-Luc Harousseau; Thierry Facon; Régis Bataille
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
Genes, chromosomes & cancer 1999;24(1):9-15.
1998: Hervé Avet-Loiseau; JY Li; Thierry Facon; Christophe Brigaudeau; Nadine Morineau; F Maloisel; Marie-Josée Rapp; Pascaline Talmant; Franck Trimoreau; Arnaud Jaccard; Jean-Luc Harousseau; Régis Bataille
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
Cancer research 1998;58(24):5640-5.
1998: Jean-Luc Harousseau
[Methods for evaluating biological response modifiers].
Bulletin du cancer 1998;85(12):993-6.
1998: Catherine Pellat-Deceunynck; S Barillé; G Jego; D Puthier; Nelly Robillard; Danielle Pineau; Marie-Josée Rapp; Jean-Luc Harousseau; Martine Amiot; Régis Bataille
The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma.
Leukemia 1998;12(12):1977-82.
1998: P Breton; P Germaud; O Morin; A F Audouin; N Milpied; Jean-Luc Harousseau
[Rare pulmonary mycoses in patients with hematologic diseases].
Revue de pneumologie clinique 1998;54(5):253-7.
1998: Noël Milpied; Fanny Gaillard; Philippe Moreau; Béatrice Mahé; J Souchet; Marie-Josée Rapp; Claude-Eric Bulabois; Nadine Morineau; Jean-Luc Harousseau
High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience.
Bone marrow transplantation 1998;22(7):645-50.
1998: Jean-Marc Classe; Marc-André Mahé; P Moreau; Marie-Josée Rapp; H Maisonneuve; A Lemevel; S Bourdin; Jean-Luc Harousseau; JC Cuillière
Ovarian transposition by laparoscopy before radiotherapy in the treatment of Hodgkin's disease.
Cancer 1998;83(7):1420-4.
1998: Hervé Avet-Loiseau; Richard Garand; Fanny Gaillard; A Daviet; Marie-Paule Mellerin; Nelly Robillard; I Bouyge; S Arcot; M Batzer; Pascaline Talmant; Jean-Luc Harousseau; Noël Milpied; Régis Bataille
Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
Genes, chromosomes & cancer 1998;23(2):175-82.
1998: Jean-Luc Harousseau
Acute myeloid leukemia in the elderly.
Blood reviews 1998;12(3):145-53.
1998: Philippe Moreau; Noël Milpied; Marie-Josée Rapp; Anne Moreau; S Bourdin; M A Mahe; B Dupas; S Le Tortorec; Mohamed Hamidou; H Maisoneuve; Béatrice Mahe; Claude-Eric Bulabois; Nadine Morineau; Henri Jardel; Jean-Luc Harousseau
Early intensive therapy with autologous stem cell transplantation in high-risk Hodgkin's disease: long-term follow-up in 35 cases.
Leukemia & lymphoma 1998;30(3-4):313-24.
1998: Philippe Moreau; Noël Milpied; Laurent Voillat; Philippe Colombat; Béatrice Mahé; Marie-Josée Rapp; Anne Moreau; B Dupas; Claude-Eric Bulabois; Nadine Juge-Morineau; Jean-Luc Harousseau
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.
Bone marrow transplantation 1998;21(12):1193-6.
1998: Philippe Moreau; V Leblond; P Bourquelot; Thierry Facon; A Huynh; Denis Caillot; O Hermine; Michel Attal; M Hamidou; G Nedellec; A Ferrant; Bruno Audhuy; R Bataille; Noël Milpied; Jean-Luc Harousseau
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.
British journal of haematology 1998;101(4):766-9.
1998: Nelly Robillard; G Jego; Catherine Pellat-Deceunynck; Danielle Pineau; D Puthier; Marie-Paule Mellerin; S Barillé; Marie-Josée Rapp; Jean-Luc Harousseau; Martine Amiot; Régis Bataille
CD28, a marker associated with tumoral expansion in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1521-6.
1998: Véronique Leblond; T Ben-Othman; Eric DECONINCK; A L Taksin; Jean-Luc Harousseau; M A Delgado; Alain Delmer; Frédéric Maloisel; X Mariette; P Morel; jean-pierre emile clauvel; P Duboisset; S Entezam; O Hermine; M Merlet; Ibrahim Yakoub-Agha; O Guibon; H Caspard; N Fort
Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2060-4.
1998: Francis Witz; Alain Sadoun; M C Perrin; Christian Berthou; J Brière; Jean-Yves Cahn; Bruno Lioure; Brigitte Witz; Sylvie François; Bernard Desablens; Bernard Pignon; P Y Le Prisé; Bruno Audhuy; Denis Caillot; Philippe Casassus; Martine Delain; B Christian; Z Tellier; Valerie Laforest; P Hurteloup; Jean-Luc Harousseau
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
Blood 1998;91(8):2722-30.
1998: Philippe Moreau; Joel Fleury; Pauline Brice; Philippe Colombat; Reda Bouabdallah; Bruno Lioure; Laurent Voillat; Olivier Casasnovas; Sylvie François; Alain Sadoun; Thierry Lamy; Jean-Pierre Lotz; Jean-Nicolas Munck; Marine Divine; Christophe Fermé; A M Pény; Christophe Fruchart; P Oriol; M Ojeda; Oumedaly Reman; Noël Milpied; Christian Gisselbrecht; Michel Legros; Jean-Luc Harousseau
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry.
Bone marrow transplantation 1998;21(8):787-93.
1998: Marc-André Mahé; S Bourdin; Annick Le Mevel; Philippe Moreau; Anne Moreau; Mohamed Hamidou; Fanny Gaillard; Marie-Josée Rapp; Noël Milpied; Jean-Luc Harousseau
Long-term results of total abdominopelvic irradiation in non-Hodgkin's lymphomas after failure of chemotherapy.
International journal of radiation oncology, biology, physics 1998;41(1):117-21.
1998: Jean-Marie Andrieu; Jean-Philippe jais; Pierre Colonna; Bernard Desablens; J Brière; Sylvie François; Jean-Luc Harousseau; Philippe Casassus; Annick LeMevel; P Y Le Prisé; Christiane Ghandour; françois guilhot; F Lejeune
Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(2):195-203.
1998: Michel Garbarz; Colette Galand; D Bibas; Odile Bournier; Isabelle Devaux; Jean-Luc Harousseau; Bernard Grandchamp; Didier Dhermy
A 5' splice region G-->C mutation in exon 3 of the human beta-spectrin gene leads to decreased levels of beta-spectrin mRNA and is responsible for dominant hereditary spherocytosis (spectrin Guemene-Penfao).
British journal of haematology 1998;100(1):90-8.
1997: N Juge-Morineau; Carlo Heirman; Marleen Bakkus; Ben Van Camp; R Malfait; Jean-Luc Harousseau; Kris Thielemans; R Bataille
Immunoglobulins D and M multiple myeloma variants are heavily mutated.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2501-6.
1997: Sylvie Hermouet; A E Niaussat; A Briec; Danielle Pineau; Nelly Robillard; Régis Bataille; Noël Milpied; Jean-Luc Harousseau; Béatrice Mahé
Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products.
Hematology and cell therapy 1997;39(6):317-25.
1997: M Paszek-Vigier; Pascaline Talmant; Françoise Méchinaud; Richard Garand; Jean-Luc Harousseau; Régis Bataille; Hervé Avet-Loiseau
Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukaemia.
British journal of haematology 1997;99(3):589-96.
1997: Jean-Luc Harousseau; Jean-Yves Cahn; Bernard Pignon; Francis Witz; Noël Milpied; Martine Delain; Bruno Lioure; Thierry Lamy; Bernard Desablens; françois guilhot; Denis Caillot; Jean-François Abgrall; S Francois; Josette Briere; Denis Guyotat; Philippe Casassus; Bruno Audhuy; Z Tellier; P Hurteloup; P Herve
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
Blood 1997;90(8):2978-86.
1997: S Barillé; C Akhoundi; Madeleine Collette; Marie-Paule Mellerin; Marie-Josée Rapp; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells.
Blood 1997;90(4):1649-55.
1997: françois guilhot; C Chastang; Mauricette Michallet; Agnès Guerci; Jean-Luc Harousseau; Frédéric Maloisel; R Bouabdallah; Denis Guyotat; N Cheron; Franck E Nicolini; Jean-François Abgrall; J Tanzer
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
The New England journal of medicine 1997;337(4):223-9.
1997: R Bataille; Jean-Luc Harousseau
Multiple myeloma.
The New England journal of medicine 1997;336(23):1657-64.
1997: Jean-Luc Harousseau
The role of colony-stimulating factors in the treatment of acute leukaemia.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1997;7(6):448-60.
1997: Jean-Luc Harousseau
[Clinical value of interferon-alpha in the treatment of malignant hematologic diseases].
Presse médicale (Paris, France : 1983) 1997;26(18):857-9.
1997: O Ringdén; Myriam Labopin; Eliane Gluckman; Jill M Hows; Benjamin A Bradley; Hans-Jochem Kolb; Loïc Fouillard; Niels Jacobsen; Jean-Paul Vernant; Francis Witz; Jean-Luc Harousseau; Norbert-Claude Gorin
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
Bone marrow transplantation 1997;19(10):963-8.
1997: Eric Jourdan; Dominique Maraninchi; Josy Reiffers; Eliane Gluckman; Bernard Rio; Jean-Pierre Jouet; Mauricette Michallet; Lysiane Molina; Eric Archimbaud; Jean-Luc Harousseau; Norbert Ifrah; Michel Attal; françois guilhot; Mathieu Kuentz; Denis Guyotat; José-Luis Pico; Charly Dauriac; Michel Legros; François Dreyfus; Pierre Bordigoni; V Leblond; Nicole Gratecos; Bruno Varet; C Auzanneau; Didier Blaise
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM).
Bone marrow transplantation 1997;19(9):875-81.
1997: Hervé Avet-Loiseau; Magda Vigier; Anne Moreau; Marie-Paule Mellerin; Fanny Gaillard; Jean-Luc Harousseau; Régis Bataille; Noël Milpied
Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas.
British journal of haematology 1997;97(1):119-22.
1997: Olle Ringdén; Myriam Labopin; E Gluckman; J Reiffers; J P Vernant; J P Jouet; Jean-Luc Harousseau; Denis Fiere; A Bacigalupo; F Frassoni; N C Gorin
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Transplantation proceedings 1997;29(1-2):733-4.
1997: M Attal; Jean-Luc Harousseau
Standard therapy versus autologous transplantation in multiple myeloma.
Hematology/oncology clinics of North America 1997;11(1):133-46.
1997: Philippe Moreau; Denis Fiere; W R Bezwoda; Thierry Facon; Michel Attal; J P Laporte; P Colombat; H L Haak; Mathieu Monconduit; H Lockhorst; D Girault; Jean-Luc Harousseau
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):660-6.
1997: Mohamed Hamidou; Christian Agard; E Fressinaud; M Fiks-Sigaud; Marie-Josée Rapp; Jean-Yves Grolleau; Jean-Luc Harousseau
[Acquired Willebrand syndrome with lymphoproliferative disorders].
Presse médicale (Paris, France : 1983) 1997;26(1):12-4.
1997: Nadine Juge-Morineau; Jean-Luc Harousseau; Martine Amiot; Régis Bataille
The retinoblastoma susceptibility gene RB-1 in multiple myeloma.
Leukemia & lymphoma 1997;24(3-4):229-37.
1997: Jean-Luc Harousseau; M Attal
The role of autologous hematopoietic stem cell transplantation in multiple myeloma.
Seminars in hematology 1997;34(1 Suppl 1):61-6.
1996: D Puthier; Régis Bataille; S Barillé; Marie-Paule Mellerin; Jean-Luc Harousseau; A Ponzio; Nelly Robillard; J Wijdenes; Martine Amiot
Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone.
Blood 1996;88(12):4659-66.
1996: Philippe Moreau; Marie-France Kergueris; Noël Milpied; S Le Tortorec; Béatrice Mahé; Claude-Eric Bulabois; Marie-Josée Rapp; C Larousse; Régis Bataille; Jean-Luc Harousseau
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.
British journal of haematology 1996;95(3):527-30.
1996: Hervé Avet-Loiseau; Marie-Claire Devilder; Richard Garand; I Bouyge; Marie-Josée Rapp; Noël Milpied; Jean-Luc Harousseau; Jean-Paul Moisan; Régis Bataille
13q14 deletions are not primary events in B-cell chronic lymphocytic leukemia: a study of 100 patients using fluorescence in situ hybridization.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(10):1673-7.
1996: Jean-Luc Harousseau; Bernard Pignon; Francis Witz; Valerie Laforest; Z Tellier; P Hurteloup; Jean-Yves Cahn
Treatment of acute myeloblastic leukemia in adults. The GOELAM experience.
Hematology and cell therapy 1996;38(5):381-91.
1996: Philippe Moreau; F Méchinaud; Béatrice Mahé; S Le Tortorec; Marie-Josée Rapp; H Maisonneuve; Jean-Luc Harousseau; Noël Milpied
Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1996;18(3):665-7.
1996: Dietrich Peest; J Bladé; Jean-Luc Harousseau; B Klein; Anders Osterborg; J F San Miguel
Cytokine therapy in multiple myeloma.
British journal of haematology 1996;94(3):425-32.
1996: Eric Solary; B Witz; Denis Caillot; Philippe Moreau; Bernard Desablens; Jean-Yves Cahn; Alain Sadoun; Bernard Pignon; Christian Berthou; Frédéric Maloisel; Denis Guyotat; Philippe Casassus; Norbert Ifrah; Y Lamy; Bruno Audhuy; Philippe Colombat; Jean-Luc Harousseau
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study.
Blood 1996;88(4):1198-205.
1996: Bernard Pignon; Francis Witz; Bernard Desablens; P Y Leprise; S Francois; C Linassier; Christian Berthou; Denis Caillot; Bruno Lioure; Jean-Yves Cahn; Philippe Casassus; Alain Sadoun; Bruno Audhuy; Denis Guyotat; J Briere; J P Vilque; Laurence Baranger; Valerie Laforest; P Berthaud; P Hurteloup; P Herve; Jean-Luc Harousseau
Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam Group.
British journal of haematology 1996;94(2):333-41.
1996: Michel Attal; Jean-Luc Harousseau; A M Stoppa; J J Sotto; J G Fuzibet; J F Rossi; P Casassus; H Maisonneuve; T Facon; N Ifrah; C Payen; R Bataille
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.
The New England journal of medicine 1996;335(2):91-7.
1996: Norbert-Claude Gorin; Myriam Labopin; Loïc Fouillard; G Meloni; F Frassoni; A Iriondo; S Brunet Mauri; Anthony H Goldstone; Jean-Luc Harousseau; J Reiffers; H Esperou-Bourdeau; E Gluckman
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1996;18(1):111-7.
1996: J Gaschet; A Lim; L Liem; Régine Vivien; Marie-Martine Hallet; Jean-Luc Harousseau; Jos Even; E Goulmy; Marc Bonneville; Noël Milpied; Henri Vié
Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
The Journal of clinical investigation 1996;98(1):100-7.
1996: P Colonna; Jean-Philippe jais; Bernard Desablens; Jean-Luc Harousseau; J Brière; M Boasson; A Lemevel; Philippe Casassus; Pierre-Yves Le Prisé; françois guilhot; Christiane Ghandour; F Lejeune; Jean-Marie Andrieu
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1928-35.
1996: I Cumin; J Y Cohen; A David; F Méchinaud; Hervé Avet-Loiseau; Jean-Luc Harousseau
Rothmund-Thomson syndrome and osteosarcoma.
Medical and pediatric oncology 1996;26(6):414-6.
1996: françois guilhot; Agnès Guerci; D Fiere; Jean-Luc Harousseau; Frédéric Maloisel; Reda Bouabdallah; Denis Guyotat; H Rochant; A Najman; Franck E Nicolini; Philippe Colombat; J F Abgrall; N Ifrah; J Brière; F Bauters; M Navarro; P Morice; Dominique Bordessoule; J P Vilque; Bernard Desablens; G Tertian; M Blanc; C Chastang; J Tanzer
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group.
Bone marrow transplantation 1996;17 Suppl 3():S29-31.
1996: P Moreau; N Milpied; P de Faucal; T Petit; P Herbouiller; R Bataille; Jean-Luc Harousseau
High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement.
Blood 1996;87(7):3063-4.
1996: Jean-Marc Navenot; D Bernard; Jean-Luc Harousseau; Jean-Yves Muller; D Blanchard
Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
Leukemia & lymphoma 1996;21(1-2):143-51.
1996: N Milpied; P Moreau; J C Cuillere; P Sagot; J H Bourhis; Jean-Luc Harousseau
Successful pregnancy after allogeneic bone marrow transplantation following conditioning including a 10-Gy single exposure total body irradiation.
Bone marrow transplantation 1996;17(3):467.
1996: I Cumin; F Mechinaud; Jean-Luc Harousseau
[Thymus hyperplasia following chemotherapy].
Presse médicale (Paris, France : 1983) 1996;25(7):291-2.
1996: Philippe Solal-Céligny; Pauline Brice; Nicole Brousse; H Caspard; Y Bastion; C Haïoun; A Bosly; Hervé Tilly; Dominique Bordessoule; C Sebban; Jean-Luc Harousseau; P Morel; B Dupas; F Plassart; N Vasile; N Fort; M Leporrier
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):514-9.
1996: Béatrice Mahé; Noël Milpied; Sylvie Hermouet; Nelly Robillard; Philippe Moreau; S Letortorec; Marie-Josée Rapp; Régis Bataille; Jean-Luc Harousseau
G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma.
British journal of haematology 1996;92(2):263-8.
1996: N Juge-Morineau; Jean-Luc Harousseau; R Bataille
[Role of glucocorticoids in the treatment of multiple myeloma].
Annales de médecine interne 1996;147(8):576-9.
1996: P Moreau; N Milpied; O Thomas; M Fiche; V Parys; J Paineau; J P Dutin; Jean-Luc Harousseau
[Primary granulocytic sarcoma of the pancreas: efficacy of early treatment with intensive chemotherapy].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(8):677-9.
1996: M Tiab; F Mechinaud; Mohamed Hamidou; F Gaillard; François Raffi; Jean-Luc Harousseau
[Hemophagocytic syndromes. A series of 23 cases].
Annales de médecine interne 1996;147(3):138-44.
1996: Jean-Luc Harousseau; B Klein
[Use of interferon alpha in multiple myeloma].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(6):488-95.
1996: P Chevalet; M Tiab; M Miegeville; N Milpied; Jean-Luc Harousseau; P Moreau
[Fusaria infection in patients with neutropenia: apropos of 3 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(6):474-6.
1996: Jean-Luc Harousseau
[Optimal control by ondansetron of acute and prolonged emesis induced by chemotherapy without cisplatin].
Bulletin du cancer 1996;83(1):71-76.
1995: T Philip; cesare guglielmi; A Hagenbeek; R Somers; H Van der Lelie; D Bron; Pieter Sonneveld; C Gisselbrecht; J Y Cahn; Jean-Luc Harousseau
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.
The New England journal of medicine 1995;333(23):1540-5.
1995: Béatrice Mahé; F Gaillard; F Labadie; S Papin; S Letortorec; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied
Occurrence of a T cell lymphoma in a patient with chronic myeloid leukemia treated with alpha interferon.
Leukemia & lymphoma 1995;19(5-6):515-7.
1995: Nadine Juge-Morineau; Marie-Paule Mellerin; S Francois; Marie-Josée Rapp; Jean-Luc Harousseau; Martine Amiot; Régis Bataille
High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells.
British journal of haematology 1995;91(3):664-7.
1995: I Cumin; F Mechinaud-Lacroix; Hervé Avet-Loiseau; A Fischer; Jean-Luc Harousseau
[Neonatal acute leukemia: apropos of 7 cases].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 1995;2(11):1060-6.
1995: Catherine Pellat-Deceunynck; S Barillé; D Puthier; Marie-Josée Rapp; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization.
Cancer research 1995;55(16):3647-53.
1995: Jean-Luc Harousseau; D Wu
The use of GM-CSF and G-CSF in the treatment of acute leukemias.
Leukemia & lymphoma 1995;18(5-6):405-12.
1995: Zhao-Yang Lu; R Bataille; P Poubelle; M J Rapp; Jean-Luc Harousseau; B Klein
An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():28-34.
1995: Jean-Luc Harousseau; M Attal; Marine Divine; G Marit; V Leblond; A M Stoppa; J H Bourhis; D Caillot; M Boasson; J F Abgrall
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():132-9.
1995: P Richard; G Amador Del Valle; P Moreau; N Milpied; M P Felice; T Daeschler; Jean-Luc Harousseau; H Richet
Viridans streptococcal bacteraemia in patients with neutropenia.
Lancet 1995;345(8965):1607-9.
1995: Jean-Luc Harousseau
[Multiple myeloma].
La Revue du praticien 1995;45(12):1540-5.
1995: Jean-Luc Harousseau; M Attal; Marine Divine; G Marit; V Leblond; A M Stoppa; J H Bourhis; D Caillot; M Boasson; J F Abgrall
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma.
Blood 1995;85(11):3077-85.
1995: Béatrice Mahé; Anne Moreau; Philippe Moreau; S Le Tortorec; Jean-Luc Harousseau; Noël Milpied
High dose radiochemotherapy followed by autologous stem cell transplantation in four patients with multiple lymphomatous polyposis.
Cancer 1995;75(11):2742-6.
1995: Eric Jourdan; Dominique Maraninchi; Josy Reiffers; Eric Archimbaud; Mauricette Michallet; Jean-Luc Harousseau; Norbert Ifrah; B Rio; D Guyotat; françois guilhot
Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de Moelle.
Leukemia 1995;9(6):1068-71.
1995: Jean-Luc Harousseau; M Attal; Marine Divine; N Milpied; G Marit; V Leblond; A M Stoppa; J H Bourhis; D Caillot; M Boasson
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
Bone marrow transplantation 1995;15(6):963-9.
1995: Zhao-Yang Lu; X G Zhang; C Rodriguez; John Wijdenes; Z J Gu; B Morel-Fournier; Jean-Luc Harousseau; R Bataille; Jean-François Rossi; Bernard Klein
Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.
Blood 1995;85(9):2521-7.
1995: Berthe-Marie Imbert-Marcille; N Milpied; M Coste-Burel; B Richet; P Moreau; Jean-Luc Harousseau; Sylviane Billaudel
Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients.
Bone marrow transplantation 1995;15(4):611-7.
1995: C Soussain; Catherine Patte; M Ostronoff; Alain Delmer; F Rigal-Huguet; N Cambier; P Y Leprisé; S François; Pascale Cony-Makhoul; Jean-Luc Harousseau
Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.
Blood 1995;85(3):664-74.
1995: H Avet-Loiseau; F Mechinaud; Jean-Luc Harousseau
Clonal hematologic disorders in Down syndrome. A review.
Journal of pediatric hematology/oncology 1995;17(1):19-24.
1994: Hervé Avet-Loiseau; F Mechinaud-Lacroix; J Y Cohen; Jean-Luc Harousseau
Probable disseminated cerebral aspergillosis: recovery with medical treatment.
Nouvelle revue française d'hématologie 1994;36(6):419-22.
1994: Philippe Moreau; S Le Tortorec; Béatrice Mahé; L Legros; Noël Milpied; Jean-Luc Harousseau
Administration of granulocyte colony-stimulating factor from day 7 after autologous bone marrow transplantation: effects on neutropenia and duration of hospitalization.
Nouvelle revue française d'hématologie 1994;36(6):455-8.
1994: Philippe Moreau; S LeTortorec; Marc-André Mahé; Béatrice Mahé; Anne Moreau; S Bourdin; Claude-Eric Bulabois; B Bureau; Jean-Luc Harousseau; Noël Milpied
Autologous bone marrow transplantation using TBI and CBV for disseminated high/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma.
Bone marrow transplantation 1994;14(5):775-8.
1994: D P Wu; Noël Milpied; Philippe Moreau; F Mechinaud-Lacroix; B Mahe; S Le Tortorec; Marie-Josée Rapp; S Bourdin; J M Mahe; Jean-Luc Harousseau
Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Bone marrow transplantation 1994;14(5):751-7.
1994: Marie-France Kergueris; N Milpied; P Moreau; Jean-Luc Harousseau; C Larousse
Pharmacokinetics of high-dose melphalan in adults: influence of renal function.
Anticancer research 1994;14(6A):2379-82.
1994: Catherine Pellat-Deceunynck; Régis Bataille; Nelly Robillard; Jean-Luc Harousseau; Marie-Josée Rapp; Nadine Juge-Morineau; J Wijdenes; Martine Amiot
Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.
Blood 1994;84(8):2597-603.
1994: Béatrice Mahé; Philippe Moreau; B Bonnemain; S Letortorec; D Menegali; S Bourdin; D De Lajartre; Jean-Luc Harousseau
Isolated Richter's syndrome of the brain: two recent cases.
Nouvelle revue française d'hématologie 1994;36(5):383-5.
1994: B Mahe; Philippe Moreau; S Le Tortorec; M Hourmant; Jean-Luc Harousseau; Noël Milpied
Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patient.
Bone marrow transplantation 1994;14(4):645-6.
1994: Y Le Normand; N Milpied; Marie-France Kergueris; Jean-Luc Harousseau
Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adult patients.
International journal of bio-medical computing 1994;36(1-2):121-5.
1993: Bruno Quesnel; H Kantarjian; J P Bjergaard; Philippe Brault; E Estey; Jean-Luc Lai; H Tilly; A M Stoppa; E Archimbaud; Jean-Luc Harousseau
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2370-9.
1993: P Moreau; J R Zahar; Noël Milpied; Olivier Baron; B Mahé; D Wu; P Germaud; Philippe Despins; A Y Delajartre; Jean-Luc Harousseau
Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection.
Cancer 1993;72(11):3223-6.
1993: Philippe Moreau; Noël Milpied; F Mechinaud-Lacroix; B Mahe; Marie-Josée Rapp; S Le Tortorec; S Bourdin; B Dupas; Jean-Luc Harousseau
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
Leukemia & lymphoma 1993;12(1-2):51-8.
1993: P Moreau; R Bataille; B Mahé; N Milpied; Jean-Luc Harousseau
High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1832.
1993: Henri Wajcman; Jean Kister; A M'Rad; Danielle Promé; N Milpied; M J Rapp; Jean-Luc Harousseau; Jean Riou; Josiane Bardakdjian; F Galacteros
Hb Saint Nazaire (beta 103[G5]Phe-->Ile): a new example of polycythemia due to a hemoglobin variant with increased oxygen affinity.
American journal of hematology 1993;44(1):16-21.
1993: Frédéric Millot; Françoise Mechinaud; Jean-Luc Harousseau; J M Mussini; Jean-François Stalder
Acute lymphoblastic leukemia associated with dermatomyositis in a child.
Pediatric dermatology 1993;10(2):199-200.
1993: Jean-Luc Harousseau; B Pignon; J Y Cahn
[Comparison between bone marrow autograft and intensive chemotherapy as treatment for maintenance of complete remission in acute myeloblastic leukemia in the adult. GOELAM Group].
Nouvelle revue française d'hématologie 1993;35(3):197-8.
1993: L Guimbretière; D Bernard; H Maisonneuve; Jean-Luc Harousseau; J Guimbretière; Jean-Yves Muller; D Blanchard
[Paroxysmal nocturnal hemoglobinuria. Diagnosis aided by a monoclonal antibody directed against the decay accelerating factor glycoprotein].
Presse médicale (Paris, France : 1983) 1993;22(10):467-71.
1993: Frédéric Millot; JL Dhondt; Françoise Mazingue; Françoise Mechinaud; J L Auget; F Bauters; Jean-Luc Harousseau
Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
Leukemia & lymphoma 1993;9(4-5):351-6.
1993: A Cesbron; P Moreau; M L Cheneau; S Cury; N Milpied; Jean-Yves Muller; Jean-Luc Harousseau; Jean-Denis Bignon
Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in primary mixed-lymphocyte reaction: application in allogeneic bone marrow transplantation.
Transplantation proceedings 1993;25(1 Pt 2):1232-3.
1993: Jean-Luc Harousseau
Is intensive treatment beneficial to elderly patients with ANLL?
Hematological oncology 1993;11 Suppl 1():4-8.
1993: P Moreau; N Milpied; A Cesbron; B Mahe; Jean-Denis Bignon; Jean-Luc Harousseau
Mixed leukocyte culture reactivity, HLA-DP typing and GVHD.
Bone marrow transplantation 1993;11(1):85-6.
1993: françois guilhot; J F Abgrall; Jean-Luc Harousseau; F Bauters; P Brice; G Dine; H Tilly; N Ifrah; P Cassasus; H Rochant
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results.
Leukemia & lymphoma 1993;11 Suppl 1():181-3.
1993: Jean-Luc Harousseau
[Autologous transplantation of hematopoietic stem cells and growth factors].
Pathologie-biologie 1993;41(1):50.
1992: H Link; M A Boogaerts; A M Carella; A Ferrant; Helmut Gadner; N C Gorin; I Harabacz; Jean-Luc Harousseau; P Hervé; J Holldack
A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.
Blood 1992;80(9):2188-95.
1992: P Moreau; N Milpied; N Fayette; J F Ramée; Jean-Luc Harousseau
Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients.
The Journal of antimicrobial chemotherapy 1992;30(4):535-41.
1992: L Detourmignies; S Castaigne; Anne-Marie Stoppa; Jean-Luc Harousseau; Alain Sadoun; Maud Janvier; J L Demory; M Sanz; R Berger; F Bauters
Therapy-related acute promyelocytic leukemia: a report on 16 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1430-5.
1992: Jean-Luc Harousseau; Noël Milpied; J P Laporte; P Collombat; T Facon; J D Tigaud; Philippe Casassus; françois guilhot; Norbert Ifrah; C Gandhour
Double-intensive therapy in high-risk multiple myeloma.
Blood 1992;79(11):2827-33.
1992: F Millot; M Lefèvre; D Blanchard; jean-christophe Rozé; Daniel Duveau; Jean-Luc Harousseau
[Intracardiac metastases of primary neuroectodermal tumor].
Archives françaises de pédiatrie 1992;49(5):449-50.
1992: Jean-Luc Harousseau
[Myeloma. Physiopathology, diagnosis, principles of treatment].
La Revue du praticien 1992;42(7):907-11.
1992: F Méchinaud-Lacroix; P Jehan; M A Debré; A M Prieur; J Sizun; Jean-Luc Harousseau
[Thrombotic manifestations and acute distal ischemia in primary antiphospholipid syndrome in children].
Archives françaises de pédiatrie 1992;49 Suppl 1():257-9.
1992: Hervé Avet-Loiseau; F Mechinaud-Lacroix; Jean-Luc Harousseau
[Ataxia telangiectasia].
Archives françaises de pédiatrie 1992;49(3):205-10.
1992: A Cesbron; P Moreau; N Milpied; Jean-Luc Harousseau; Jean-Yves Muller; Jean-Denis Bignon
Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction.
Human immunology 1992;33(3):202-7.
1992: Jean-Luc Harousseau; Bernard Pignon; P Dufour; Norbert Ifrah; Eric Solary; J F Abgrall; Noël Milpied; Bernard Desablens; Denis Guyotat; P Herve
Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AML.
Leukemia 1992;6 Suppl 2():120-3.
1992: B Klein; Zhao-Yang Lu; Philippe Gaillard; Jean-Luc Harousseau; R Bataille
Inhibiting IL-6 in human multiple myeloma.
Current topics in microbiology and immunology 1992;182():237-44.
1991: M Maigre; P Guerzider; Jean-Luc Harousseau
[Systemic mastocytosis and malignant hemopathies. Review of the literature apropos of a case].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1991;12(5):343-9.
1991: Jean-Luc Harousseau; Noël Milpied; J Briere; Bernard Desablens; P Y Leprise; N Ifrah; B Gandhour; Philippe Casassus
Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1432-7.
1991: Philippe Moreau; Pascaline Talmant; Noël Milpied; Richard Garand; G Lefranc; Jean-Luc Harousseau
Trisomy 4 associated with acute lymphocytic leukaemia.
British journal of haematology 1991;78(4):576.
1991: Jean-Luc Harousseau; Noël Milpied; J Briere; Bernard Desablens; P Y Leprise; N Ifrah; B Gandhour; Philippe Casassus
Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
Seminars in hematology 1991;28(3 Suppl 4):80-3.
1991: F Millot; F Mechinaud-Lacroix; G Picherot; Jean-Luc Harousseau
[Cerebral granulocytic sarcoma disclosing acute non-lymphoblastic leukemia].
Archives françaises de pédiatrie 1991;48(2):123-5.
1991: Jean-Luc Harousseau; F Huguet; J Reiffers; P Collombat; P Kohser; P L Prise; P Souteyrand; P Hurteloup
Oral idarubicin and low dose cytarabine as the initial treatment of acute myeloid leukemia in elderly patients.
Leukemia & lymphoma 1991;5(2-3):145-9.
1991: Jean-Luc Harousseau; Noël Milpied; J P Jouet; P Colombat; françois guilhot; J P Laporte; Norbert Ifrah; C Gandhour; Philippe Casassus
Intensive therapy for high grade multiple myeloma (MM).
Bone marrow transplantation 1991;7 Suppl 2():28.
1991: françois guilhot; J P Lamagnère; Jean-Luc Harousseau; H Tilly; P Casassus; N Ifrah; H Rochant; F Bauters; G Dine; J Tanzer
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results.
European journal of cancer (Oxford, England : 1990) 1991;27 Suppl 4():S26.
1991: N Milpied; Jean-Luc Harousseau; P Moreau; F Lacroix; J F Ramee; S Billaudel
DHPG at CMV viremia after allogeneic bone marrow transplantation. Result over a four year period (1986-1990).
Bone marrow transplantation 1991;7 Suppl 2():46.
1990: A Cesbron; P Moreau; N Milpied; Jean-Yves Muller; Jean-Luc Harousseau; Jean-Denis Bignon
Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;6(5):337-40.
1990: N Milpied; Christian Gisselbrecht; Jean-Luc Harousseau; C Sebban; Francis Witz; X Troussard; N Gratecos; Mauricette Michallet; V LeBlond; G Auzanneau
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.
Cancer 1990;66(4):627-31.
1990: D Boudart; J C Lucas; J Y Muller; D Le Carrer; Bernard Planchon; Jean-Luc Harousseau
False-positive hepatitis C virus antibody tests in paraproteinaemia.
Lancet 1990;336(8706):63.
1990: Vincent Praloran; Irène Dobo; Richard Garand; M Klausman; M F Naud; Noël Milpied; Jean-Luc Harousseau
Collagen gel cultures for detection of spared hematopoietic progenitors in Asta Z 7557 purged human marrows.
Leukemia 1990;4(4):282-6.
1990: Eric Lepage; C Sebban; Christian Gisselbrecht; Bertrand Coiffier; Jean-Luc Harousseau; P A Bryon; M Boiron
Treatment of low-grade non-Hodgkin's lymphomas: assessment of doxorubicin in a controlled trial.
Hematological oncology 1990;8(1):31-9.
1990: Jean-Luc Harousseau; Noël Milpied; J Briere; Bernard Desablens; P Y Le Prise; Norbert Ifrah; C Gandhour; Philippe Casassus
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
Haematology and blood transfusion 1990;33():299-303.
1990: Jean-Luc Harousseau; Noël Milpied; J Brière; Bernard Desablens; Christiane Ghandour
Mitoxantrone and intermediate-dose cytarabine in relapsed or refractory acute myeloblastic leukemia.
Nouvelle revue française d'hématologie 1990;32(4):227-30.
1990: Philippe Colombat; P Biron; C Patte; Jean-Luc Harousseau; F Demeocq; E Benz-Lemoine; D Frappaz; J P Lamagnère; T Philip
High-dose etoposide and cisplatin in refractory or recurrent non-Hodgkin's lymphomas (NHL).
Nouvelle revue française d'hématologie 1990;32(3):183-6.
1989: Jean-Luc Harousseau
[Acute myeloblastic leukemias. Diagnosis, clinical course and prognosis].
La Revue du praticien 1989;39(30):2745-8.
1989: Bernard Desablens; J M Tourani; Philippe Casassus; J Brière; Jean-Luc Harousseau; A Lemevel; Norbert Ifrah; P Y Le Prise; C Gandhour; françois guilhot
[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol].
Presse médicale (Paris, France : 1983) 1989;18(39):1917-21.
1989: Jean-Luc Harousseau
[Evaluation of interferons in hemato-oncology].
Pathologie-biologie 1989;37(9):1016-7.
1989: N Milpied; N Ifrah; M Kuentz; D Maraninchi; P Colombat; D Blaise; Jean-Luc Harousseau
Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission.
British journal of haematology 1989;73(1):82-7.
1989: Denis Fière; Michel Marty; P Solal-Celigny; Jean-Luc Harousseau; N C Gorin; Bernard Desablens; J Brière; B David; Dominique Bordessoule; M Hayat
[Intensive induction and early consolidation of acute lymphoid leukemia in the adult. A pilot study of feasibility and long-term development].
Presse médicale (Paris, France : 1983) 1989;18(5):221-3.
1989: Vincent Praloran; M Klausman; M F Naud; Jean-Luc Harousseau
Blood erythroid progenitors (CFU-E and BFU-E) in acute lymphoblastic leukemias.
Blut 1989;58(2):75-8.
1989: Jean-Luc Harousseau; Françoise Rigal-Huguet; P Hurteloup; H Guy; Noël Milpied; Jacques Pris
Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agent.
European journal of haematology 1989;42(2):182-5.
1989: Jean-Luc Harousseau; Josy Reiffers; P Hurteloup; Noël Milpied; H Guy; Françoise Rigal-Huguet; T Facon; Patrick Dufour; N Ifrah
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):45-9.
1989: Jean-Luc Harousseau
[New therapeutic approaches in multiple myeloma].
Annales de médecine interne 1989;140(1):45-9.
1988: N Milpied; J H Bourhis; R Garand; Jean-Luc Harousseau
B cell all in an anti-HIV positive patient: achievement of a complete response with aggressive chemotherapy.
British journal of haematology 1988;70(4):501-2.
1988: R Cariou; Jean-Luc Harousseau; G Tobelem
Inhibition of human endothelial cell proliferation by heparin and steroids.
Cell biology international reports 1988;12(12):1037-47.
1988: S Bellucci; Jean-Luc Harousseau; P Brice; G Tobelem
Treatment of essential thrombocythaemia by alpha 2a interferon.
Lancet 1988;2(8617):960-1.
1988: Jean-Luc Harousseau; N Milpied; Alain Reynaud; M Derriennic; J H Bourhis; A L Courtieu
[Prophylactic systemic antibiotherapy with only ceftriaxone in neutropenic patients treated in a protected environment].
Pathologie-biologie 1988;36(7):907-11.
1988: Jean-Luc Harousseau; N Milpied; françois guilhot; R Garand; J H Bourhis
[First-line treatment of severe myelomas of the young subject by high-dose melphalan].
Presse médicale (Paris, France : 1983) 1988;17(29):1471-4.
1988: Jean-Luc Harousseau; Françoise Mechinaud; Xavier Rialland; N Milpied; F Nomballais; J Y Cohen; JC Cuillière; François Legent
[Role of chemotherapy in the treatment of esthesioneuroblastoma in children. Apropos of 3 case reports].
Annales de pédiatrie 1988;35(6):383-6.
1988: Jean-Luc Harousseau; N Milpied; J H Bourhis; L Guimbretière; P Talmant
[Lethal aplasia after treatment with alpha-interferon of recurrent chronic myeloid leukemia following allogeneic bone marrow graft].
Presse médicale (Paris, France : 1983) 1988;17(2):80-1.
1987: Jean-Luc Harousseau; N Milpied; R Garand; J H Bourhis
High dose melphalan and autologous bone marrow transplantation in high risk myeloma.
British journal of haematology 1987;67(4):493.
1987: Jean-Luc Harousseau; N Milpied; Alain Reynaud; M Derriennic; J H Bourhis; A L Courtieu
[Preventive systemic antibiotherapy with ceftriaxone alone in neutropenic patients treated in a protected environment].
Presse médicale (Paris, France : 1983) 1987;16(35):1737-40.
1987: Jean-Luc Harousseau; P Hurteloup; Josy Reiffers; Françoise Rigal-Huguet; M Hayat; Patrick Dufour; P Y Le Prise; M Monconduit; J Jaubert; Y Carcassonne
Idarubicin in the treatment of relapsed or refractory acute myeloid leukemia.
Cancer treatment reports 1987;71(10):991-2.
1987: Guy Leverger; F Demeocq; Jean-Luc Harousseau; O Taboureau; Jean-Pierre Vannier; A Boilletot; Lionel de Lumley; Patrick Boutard; D Olive; P Reinert
[Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
Pathologie-biologie 1987;35(5):648-51.
1987: C Lacombe; Y Blouquit; Nicole Arous; Jean Riou; Jean-Luc Harousseau; Josiane Bardakdjian; N Milpied; F Galacteros
Hb Potomac [beta 101(G3)Glu----Asp] in a Polish family living in France.
Hemoglobin 1987;11(1):55-9.
1987: J Robert; Françoise Rigal-Huguet; Jean-Luc Harousseau; Jacques Pris; S Huet; Josy Reiffers; P Hurteloup; V Tamassia
Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patients.
Leukemia research 1987;11(11):961-4.
1987: S Collado; Michel Marty; Marie-Thérèse Daniel; Jean-Luc Harousseau; Dominique Bordessoule; Jean-Marc Extra; Laurent Degos; G Schaisson; M Boiron
[Improved results in the treatment of acute monoblastic leukemia: analysis of 91 patients treated in the 01 AM 81 protocol].
Nouvelle revue française d'hématologie 1987;29(4):215-20.
1987: Michel Marty; Eric Lepage; H Guy; Dominique Bordessoule; Bernard Desablens; Jean-Luc Harousseau; françois guilhot; G Leverger; G Schaison; M Boiron
Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study.
Haematology and blood transfusion 1987;30():50-6.
1987: G Schaison; G Leverger; A Bancillon; Michel Marty; D Olive; G Cornu; C Griscelli; S Lemerle; Jean-Luc Harousseau; M Bonnet
Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.
Haematology and blood transfusion 1987;30():461-5.
1986: D Maraninchi; J P Vernant; E Gluckman; A Bordigoni; D Fiere; M Freycon; N Gratecos; Jean-Luc Harousseau; M Flesch; V Leblond-Missenard
[Allogenic bone marrow grafts in acute myeloid leukemias. A retrospective study in 111 grafted patients in first complete remission].
Presse médicale (Paris, France : 1983) 1986;15(42):2093-6.
1986: F Sigaux; G Flandrin; F Valensi; P Gaulard; S Castaigne; M T Daniel; Jean-Luc Harousseau
Can peripheral T-cell lymphomas be morphologically subclassified? A morphometric approach to 21 cases.
Cytometry 1986;7(4):371-7.
1986: T Philip; J Dumont; F Teillet; D Maraninchi; N C Gorin; M Kuentz; Jean-Luc Harousseau; M Marty; R Pinkerton; P Herve
High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.
British journal of cancer 1986;53(6):737-42.
1986: R Cariou; Jean-Luc Harousseau; P Dubigeon; O Rodat; Y Lenne; J Y Grolleau
[Osteomedullary amyloidosis with osteolytic lesions. Apropos of 4 cases].
Annales de médecine interne 1986;137(5):409-14.
1986: B Dreno; N Milpied; Jean-Luc Harousseau; Jean-François Stalder; B Bureau; B Milpied; H Barriere
Cutaneous immunological studies in diagnosis of acute graft-versus-host disease.
The British journal of dermatology 1986;114(1):7-15.
1985: J P Soulillou; J Y Douillard; H Vie; Jean-Luc Harousseau; J Guenel; A le Mevel-le Pourhiet; B le Mevel
Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
European journal of cancer & clinical oncology 1985;21(8):935-9.
1985: R Cariou; Jean-Luc Harousseau; M J André; Pascaline Talmant; B Bray; Richard Garand
[Chromosome 3 abnormalities with dysmegakaryocytopoiesis in in subacute transformation in chronic myeloid leukemia].
Nouvelle revue française d'hématologie 1985;27(1):23-6.
1984: Jean-Luc Harousseau; S Castaigne; N Milpied; M Marty; L Degos
Treatment of acute non-lymphoblastic leukaemia in elderly patients.
Lancet 1984;2(8397):288.
1984: Jean-Luc Harousseau
[Hodgkin's disease. Etiology--physiopathology].
La Revue du praticien 1984;34(21):1037-8, 1041-3.
1984: J M Brisseau; O Rodat; F Buzelin; L Le Bodic; J Lucas; Jean-Luc Harousseau; M Alliot
[Hepatic granulomatous localizations in Whipple's disease. Apropos of 2 cases].
Archives d'anatomie et de cytologie pathologiques 1984;32(6):361-4.
1983: J M Brisseau; O Rodat; F Buzelin; L Le Bodic; J Lucas; Jean-Luc Harousseau; M Alliot
[Granulomatous hepatic localizations in Whipple's disease. Apropos of 2 cases].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1983;59(42):2889-92.
1983: O Rodat; F Buzelin; M Weber; J Barrier; Jean-Luc Harousseau; G Rodat; J Mussini-Montpellier
[Bronchopulmonary manifestations of Horton's disease. Apropos of a case].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1983;4(3):225-30.
1983: Jean-Luc Harousseau; X Vallantin; G Tricot; C Gisselbrecht; C Jacquillat
[Neuromeningeal localizations in non-Hodgkin's lymphomas in adults].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1983;59(4):221-5.
1983: N Milpied; Jean-Luc Harousseau; S Castaigne; B Bureau; C Reynaud; O Rodat
[Lesions evoking Sweet's syndrome in acute leukemia: occurring during the stage of therapeutic aplasia].
Annales de médecine interne 1983;134(1):38-41.
1982: O Rodat; Jean-Luc Harousseau; C Reynaud; N Milpied; J F Stalder; M Chupin
[Eosinophilic fasciitis and Hodgkin's disease].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1982;58(38):2207-9.
1982: Jean-Luc Harousseau; Guido Tricot; C Gisselbrecht; B Asselain; G Flandrin
[Mediastinal lymphomas in adults. A clinical and histological study of 30 cases (author's transl)].
La Nouvelle presse médicale 1982;11(18):1393-6.
1981: Françoise Homo-Delarche; Sylvie Durant; D Duval; J P Marie; R Zittoun; Jean-Luc Harousseau
Glucocorticoid receptors and hormonal responsiveness of human blood and bone-marrow cells in non-lymphocytic leukemia.
Journal of steroid biochemistry 1981;15():479-85.
1981: C Foldes; G Schaison; Jean-Luc Harousseau; A Marcelli
[Major hyperleukocytosis, exceeding 100 000 in immune quinine-induced hemolysis (author's transl)].
Annales de pédiatrie 1981;28(9):660-2.
1981: Françoise Homo-Delarche; D Duval; J P Marie; R Zittoun; Jean-Luc Harousseau
[Glucocorticoid receptors and leukemia (author's transl)].
Annales d'endocrinologie 1981;42(4-5):315-20.
1981: Jean-Luc Harousseau; G Flandrin; Guido Tricot; J C Brouet; M Seligmann; J Bernard
Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases.
Cancer 1981;48(6):1302-8.
1981: O Rodat; P Lemouroux; Jean-Luc Harousseau
[Wissler-Fanconi syndrome or polyarthritis caused by Yersinia pseudotuberculosis?].
La Nouvelle presse médicale 1981;70(12):987-8.
1980: Jean-Luc Harousseau; J M Andrieu; J Dumont; B Montagnon; B Asselain; M T Daniel; G Flandrin
[Acute myeloblastic leukaemia in the course of non-Hodgkin's lymphoma (author's transl)].
La Nouvelle presse médicale 1980;9(46):3513-6.
1980: Jean-Luc Harousseau; G Tobelem; G Schaison; C Chastang; M F Auclerc; M Weil; C Jacquillat; J Bernard
High risk acute lymphocytic leukemia: a study of 141 cases with initial white blood cell counts over 100,000/cu mm.
Cancer 1980;46(9):1996-2003.
1980: S Belluci; G Schaison; Jean-Luc Harousseau; G Flandrin; P Henon
[Celiac disease manifested by folate deficiency simulating severe blood disease].
La Nouvelle presse médicale 1980;9(30):2077-8.
1980: Françoise Homo-Delarche; D Duval; Jean-Luc Harousseau; J P Marie; R Zittoun
Heterogeneity of the in vitro responses to glucocorticoids in acute leukemia.
Cancer research 1980;40(7):2601-8.
1980: Jean-Luc Harousseau; G Schaison; I Caubarrere; Guido Tricot
[Acute lymphoblastic leukemia. Late testicular relapse associated with lymph node sarcoidosis].
La Nouvelle presse médicale 1980;9(18):1310.
1980: Jean-Luc Harousseau
[Clinical aspects of acute leukemia].
Revue de l'infirmière 1980;30(2):21-4.
1980: F Homo; Sylvie Durant; D Duval; J P Marie; R Zittoun; Jean-Luc Harousseau
In vitro hormonal responsiveness of human blood and bone marrow cells in non-lymphocytic leukemia.
Leukemia research 1980;4(6):619-28.
1980: C Jacquillat; M Weil; M F Auclerc; G Schaison; C Chastang; Jean-Luc Harousseau; F Bauters; D Olive; C Griscelli; M Bonnet; J P Lamagnere; J Bernard
Application of the study of prognostic factors to the treatment of childhood (less than 20 years old) acute lymphoblastic leukemia.
Bulletin du cancer 1980;67(4):458-69.
1979: Jean-Luc Harousseau; G Tobelem; G Schaison; C Jacquillat
[Acute lymphoblastic leukemia with hyperleucocytosis: an urgent problem during initial treatment (author's transl)].
La Nouvelle presse médicale 1979;8(22):1827-30.
1979: C Caron-Chiarazzo; Jean-Luc Harousseau; F Desmons
[Cutaneous lesions of malignant histiocytosis. About five cases (author's transl)].
Annales de dermatologie et de vénéréologie 1979;106(5):471-8.
1979: M Krulik; R Sitruk-Ware; M Mougeot-Martin; A A Audebert; D Zylberait; Jean-Luc Harousseau; J Debray
[Solitary secreting plasmocytoma. Apropos of three cases and a review of the literature].
L'unión médicale du Canada 1979;108(2):152-62, 192.
1979: Jean-Luc Harousseau; L Degos; M T Daniel; G Flandrin
Leukemic phase of malignant histiocytosis (arguments in favour of the histiomonocytic origin of the abnormal cells).
Medical and pediatric oncology 1979;6(4):339-46.
1978: Jean-Luc Harousseau; N Smadja; M Krulik; A A Audebert; J Debray
[Study of caryotype in pre-leukaemic states (author's transl)].
La Nouvelle presse médicale 1978;7(38):3431-5.
1978: Jean-Luc Harousseau; G Tobelem; G Schaison; C Jaquillat
[Hodgkin's disease appearing during acute leukemia in remission].
La Nouvelle presse médicale 1978;7(34):3054.
1978: G Tobelem; Jean-Luc Harousseau; N Lemercier; G Flandrin; C Jacquillat; G Schaison
[Initial medullary necrosis during acute lymphoblastic leukemia. Value of medullary scintigraphy].
La Nouvelle presse médicale 1978;7(32):2865.
1978: J F Bernard; Jean-Luc Harousseau; M Renoux; D Dhermy; A Cooper-Nataf; P Boivin
[Extramedullary lymphosarcoma, erythroblastopenia and gastric adenocarcinoma. Apropos of a case].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1978;54(25-28):818-20.
1978: M Mougeot-Martin; M Krulik; Jean-Luc Harousseau; A A Audebert; Y Chaouat; J Debray
[Cases of acute leukaemia following immunosuppressive therapy for disseminated sclerosis and for Behçet's syndrome (author's transl)].
Annales de médecine interne 1978;129(3):175-80.
1977: E Kaloustian; Jean-Luc Harousseau; M Krulik; M Mougeot-Martin; J L Brault; J Debray
[Effect of levamisole on the peripheral lymphocyte population (T and B lymphocytes) in 2 cases of chronic lymphocytic leukemia].
La Nouvelle presse médicale 1977;6(45):4208-9.
1977: Jean-Luc Harousseau; N Smadja; M Krulik; A A Audebert; J Debray
[Inagural lymphoblatic transformation in chronic myeloid leukemia. Clinical and cytogenetic study of one case].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1977;53(42):2437-44.
1977: M Krulik; J Y Grolleau; A A Audebert; M Mougeot-Martin; Jean-Luc Harousseau; D Hervouet; J Debray
[Acute granulous leukemia in multiple myeloma. Apropos of 5 cases].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1977;53(42):2425-35.
1977: C Dao; Jean-Luc Harousseau; C de Carbonniéres; J Bousser; G Bilski-Pasquier
[Erythrocytic and immunologic abnormalities in myeloid splenomegaly].
Nouvelle revue française d'hématologie; blood cells 1977;18(3):619-26.
1974: A Najman; Jean-Luc Harousseau; N C Gorin; G Duhamel; R André
[Course of refractory anemias. Study of 49 cases].
Annales de médecine interne 1974;125(10):703-9.
1974: A Najman; J H Gaudy; G Gasne; N C Gorin; Jean-Luc Harousseau
[Association of polyglobulia and fibroma. Study of a case].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1974;50(9):633-5.